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II. Summary 
 
 
The gene encoding fumarase (fum) from Thermus thermophilus was expressed in yeast 
Saccharomyces cerevisiae. The recombinant cells were heated at 70°C to inactivate 
indigenous enzymes and used for the bioconversion of fumaric acid to L-malic acid. By 
heating the host cells at 70°C, substrate is able to go across the heat-damaged membrane of 
the microorganism and a desired product can be formed. This new concept, called Synthetic 
Metabolic Engineering (SME), has already been applied successfully in Escherichia coli. 
Unfortunately, E. coli membrane is weakened too much during the heat treatment and enzyme 
leakage appears. The surface structure of yeast is more rigid than that of E. coli and this might 
be taken as an advantage for application of SME. When continuous or repeated-batch reaction 
is carried out, enzyme leakage becomes a major drawback. It is assumed that yeast cells could 
overcome this problem by retaining more enzymes in the cell during and after the heat 
treatment.  
In order to prove this hypothesis, a thermophilic fumarase (FUM) was over-expressed in two 
hosts, S. cerevisiae as well as E. coli. fum was first modified to be over-expressed in yeast 
cells and FUM was successfully produced in yeasts. Optimization of SME techniques was 
carried out for yeast cells. Then, enzyme activity and enzyme leakage was investigated for 
both strains. E. coli showed high level of FUM expression, though considerable amount of 
enzyme leaked to supernatant. On the other hand, even though the level of FUM expression in 
S. cerevisiae was low, yeast cells overcome leakage problem and are re-usable. This study 
showed the first trial of SME in yeast cells and possibility of utilization of yeast as a host 
strain for SME. 
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III. Tables 
Abbreviations Table 
Abbreviation Full name 
amp Ampicillin 
BSA Bovine serum albumin 
CIAP Calf intestinal alkaline phosphatase 
Cm Chloramphenicol 
DMSO Dimethyl sulfoxide 
DTT Dithiothreitol 
E. coli Escherichia coli 
EDTA Ethylene diaminetetraacetic acid 
EtBr Ethidium Bromide 
FA Fumaric Acid, fumarate 
FDA Food and Drug Administration 
FUM Fumarase, Fumarate hydratase 
fum Gene encoding fumarase 
GB Glass Beads shaking 
GB-DTT Glass beads shaking with DTT incubation 
GRAS Generally Regarded As Safe 
His Histidine 
HPLC High Pressure Liquid Chromatography 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
LB Luria-Bertani medium 
LMA L-malic acid, L-malate 
ME Malic enzyme 
NAD+ Nicotinamide adenine dinucleotide 
NADH Reduced form of NAD+ 
NADP+ Nicotinamide adenine dinucleotide phosphate 
NADPH Reduced form of NADP+ 
NBRP National Bio-Resource project 
OD Optical density 
ODCase Orotidine-5’-phosphate decarboxylase 
ON Overnight 
PAE Post-alkaline extraction 
PAGE Polyacrylamide gel electrophoresis 
pBS pBlueScript vector 
PBS Phosphate buffer salines 
PCR Polymerase chain reaction 
R. opacus Rhodococcus opacus 
rpm Rotation per minute 
RT Room Temperature 
S. cerevisiae Saccharomyces cerevisiae 
SDmin Synthetic dextrose minimal medium 
SD+HIS SDmin + histidin 
SDS Sodium dodecyl sulfate 
SN Supernatant 
T. kodakaraensis Thermococcus kodakaraensis KOD1 
T. thermophilus Thermus thermophilus 
TEs  Thermophilic enzymes 
TEMED Tetramethylethylenediamine (CH3)2NCH2CH2N(CH3)2 
Tris tris(hydroxymethyl)aminomethane 
URA3 Gene encoding ODCase 
X-gal Bromo-chloro-indolyl-galactopyranoside 
YAC Yeast artificial chromosome 
YCp Yeast centromere plasmid 
YEPD Yeast extract peptone dextrose medium 
YEp Yeast Episomal Plasmid 
YIp Yeast Integrative Plasmid 
 D 
 
Origin of used chemicals, substances and instruments 
Name Details Manufacturer 
Agar Powder Wako 
Ampicillin anhydrous Wako 
BigDye Terminator v3.1 sequencing Applied Biosystems 
Biorad protein assay dye reagent concentrate BIO-RAD 
blunt end buffer for T4 kinase treatment Toyobo 
Chloramphenicol  Wako 
CIAP  Takara 
Coomassie Brilliant Blue R-250 staining solution BIO-RAD 
denaturation buffer for T4 kinase treatment Toyobo 
dNTPs for PCR Takara 
exTaq polymerase  Takara 
exTaq polymerase buffer  Takara 
Filter Avodisc syringe filter with 0.2 µm membrane Pall corporation 
Glass Beads and tubes BSP-11079105W Wakenyaku 
HPLC  Shimadzu 
HPLC Program LC Solution V.1.25 Shimadzu 
HPLC column  Nacalai Tesque 
IPTG  Nacalai tesque 
kit for extraction from 
agarose gel 
Illustra GFX PCR DNA and Gel band 
purification kit 
GE Healthcare 
kit for plasmid extraction WizardPlus SV Minipreps DNA purification  Promega 
LB broth  Nacalai tesque 
M13 primers  Invitrogene 
NAD+/NADH  Oriental Yeasts 
NADP+/NADPH  Oriental Yeasts 
PCR device C1000 Thermal cycler BIO-RAD 
Peptone Enzymatic digest of protein Bacto 
PrimeStar Premix for PCR Takara 
rATP for T4 kinase treatment Toyobo 
Restriction enzymes  Takara 
Restriction enzymes buffer  Takara 
Spectrophotometer UV-2450 UV-VIS Spectrophotometer Shimadzu 
Standard buffer solutions  Nacalai tesque 
T4 kinase  Toyobo 
TEMED  Funakoshi 
Transformation kit for yeasts Frozen EZ yeast transformation kit Zymo reseqrch 
Tryptone Pancreatic digest of casein Bacto 
X-gal  Nacalai tesque 
Yeast Extract extract of autolysed yeast cells Bacto 
Yeast Nitrogen without 
amino acids 
based for classifying yeasts Difco 
10x Tris/Glycine/SDS buffer  BIO-RAD 
10x loading buffer for gel electrophoresis Takara 
2-log DNA ladder for gel electrophoresis New England Biolabs 
2x ligation mix  Wako 
Thermus HB8 genome  Harima Riken 
All the other chemicals not mentioned in this list come from Wako or Nacalai tesque.  
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IV. Introduction 
Organisms with an optimal growth temperature above 60°C are called thermophiles. 
Coming from thermophiles, thermophilic enzymes (TEs) are usually resistant to inactivation 
at high temperature and optimally active above 60°C. TEs are nevertheless very similar to 
mesophilic enzymes and share with them catalytic mechanisms [Vieille et al., 1996]. TEs 
amino acid sequences are 40-85% similar to mesophilic ones and their 3-dimensional 
structures are alike [Vieille and Zeikus, 1996]. There is no systematic structural difference 
between extremely stable and normal protein. It so happens that TEs are more rigid at room 
temperature (RT), which gives the protein a protection from unfolding and preservation of 
catalytically active structure [Bruins et al., 2001].  
TEs have many advantages compared to enzymes from mesophilic organisms [Cava et al. 
2009] as they show increased resistance to denaturing chemical agents [Khajeh et al., 2001]. 
Thermophiles have high growth rate as well as high cell yields and their enzymes are easily 
crystallized. They are also the closest living representatives of the last bacterial common 
ancestors and, therefore, become subject matter of primitive life. They possess a large number 
of conserved genes. Their genome size being really small, very few functional paralogues 
exist and their stability is very high. Although thermophiles have such attractive features, their 
potential problems in cultivation have prevented application to industrial use. As they require 
high temperature cultivation, dehydration of the medium might happen; glass plates and 
thermo-resistant equipment should be used. The instability of several growth medium 
components as well as the combination with other extremophilic characters (such as a high or 
low pH, or different salt conditions), also hamper the cultivation of the organisms [Cava et al., 
2009].  
Production of thermophilic enzymes in mesophilic hosts has many advantages to overcome 
above-mentioned problems in thermophiles [Honda et al. 2010]. Many mesophilic hosts are 
common organisms to use in laboratories and are then well-studied. They don’t require 
specific growth conditions (such as a high temperature or a high pH). Moreover, the thermal 
properties of TEs are retained when cloned in mesophilic hosts [Vieille et al., 1996] and TEs 
are readily purified only by heating at high temperature as endogenous enzymes of mesophilic 
hosts are inactivated. Utilizing such features, synthetic metabolic engineering (SME) has 
emerged as a novel bioprocess. SME is based on expression of a series of thermophilic 
enzymes that catalyze objective reactions in mesophilic host and inactivation of enzymes 
derived from host organism at high temperature. This will eliminate unwanted side reactions 
[Restiawaty et al., 2011; Honda et al., 2010; Iwamoto et al., 2007] and only desirable product 
could be obtained. In addition, this treatment will partially disrupt the cell membrane and the 
substrate accessibility will be improved. Based on SME, construction of an artificial bio-
synthetic pathway that transform fructose to 2-deoxyribose 5-phosphate has already been 
demonstrated [Honda et al., 2010]. Fructose 1,6-diphosphate from fructose and polyphosphate 
was also achieved based on SME [Iwamoto et al., 2007]. Such studies have demonstrated the 
power of SME using E. coli as a host strain.  
To further expand application of SME, it is desirable to investigate other candidates as host 
strain, as SME employing E. coli has some restrictions at the present time. Although E. coli is 
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a very good host for protein expression and its gene modification tool is abundant, its thin 
membrane allows leakage of many proteins as well as the enzyme of interest out of the cells 
after heat treatment [Tsuchido et al., 1985; Restiawaty et al., 2011]. This therefore might 
make the cells not reusable. Inability of protein production requiring post-translation and 
production of toxic product such as endotoxin in high concentration cultivation are also 
disadvantages of E. coli. 
Yeast cells provide an appealing alternative to protein expression in bacterial cells. They 
have many advantages compared to other kinds of hosts as their gene manipulation is easy 
and they are capable of secretion and modification of proteins [Barnett, 2000; Strathern, 1981]. 
They are also classified as Generally Regarded As Safe (GRAS) by the U.S Food and Drug 
Administration (FDA) [Nevoigt, 2008]. It is also believed that the yeast membrane should 
resist better to heat treatment, and less protein should leak out of the cell. Such attractive 
features of yeast promoted me to investigate possibility of yeast as a host strain for SME. 
Production of TE has already been applied successfully in many kinds of yeasts [Lòpez-
Lòpez et al. 2009; Kiiskinen et al. 2004; Rocha et al. 2010; Chen et al. 2007; Zamocky et al. 
2008; Li et al. 2009]. All of those publications have in common the fact that the thermostable 
protein expressed in the specific yeast strain is secreted by the host (in an active form for 
some of them [Chen et  al., 2007]). Sometimes secreted naturally, the proteins have also been 
modified in order to be secreted. An example was demonstrated by Lòpez-Lòpez and co-
workers [Lòpez-Lòpez et al. 2009], where the putative signal peptide was replaced by the 
S. cerevisiae α-factor secretion signal. Kiiskinen and co-workers [Kiiskinen et al. 2004], also 
showed that with the α-factor and modified cDNA having a stop codon after the native 
processing site at the C terminus, the production could be increased six folds. Although these 
studies successfully demonstrated secretion of TEs, intracellular production of TEs and 
construction of an artificial bio-synthetic pathway have not been demonstrated in yeast. 
Therefore, the creation of an artificial biosynthetic pathway in the yeast cells of 
Saccharomyces cerevisiae was investigated in this project. As a model enzyme, fumarase 
(FUM) from T. thermophilus HB8 is selected for the bioconversion of fumaric acid (FA) 
to L-malic acid (LMA), based on SME. Fumarase can be found in two different forms. The 
cytosolic one is involved in the metabolism of amino acids, while the mitochondrial one is 
involved in Krebs’s cycle. Malic acid is nowadays used mainly in the food, cosmetics and 
pharmaceutical industries and is mostly produced by chemical synthesis or hydratation of 
fumarate by either immobilized cells or fumarase. It has been identified by the U. S. 
Department of Energy as a substance that could be made from renewable carbohydrates in 
large quantities [Zhang et al., 2010]. In the Krebs’s cycle, fumarase is responsible for the 
hydratation of fumarate into L-malate, without addition of any cofactor [Koolman and Röhm, 
2004]. Another aim of this project is comparison of S. cerevisiae and E. coli as host 
strains for SME. Therefore FUM was also expressed in E. coli and enzyme production and 
activity were compared with yeast strain. Enzyme leakage and reusability of cells expressing 
FUM were also compared. This is the first report of SME on yeast and comparison of SME on 
E.coli. 
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V. Materials and Methods 
 
V.1 Organisms 
V.1.1 Escherichia coli  
The bacterial strains used in this study are E. coli Rosetta (DE3) pLysS, for protein 
expression, and DH5α and JM109 for plasmid amplification. The three of them were available 
in our laboratory, in the glycerol stock.  
JM109 is a derivative of K strain bacteria and has recA and endA genotype. This strain also 
has lacZ mutation (allowing for blue/white selection). Sensitive to all common antibiotics, 
JM109 transformants can be obtained using antibiotic marker gene on plasmid, and 
transformants were obtained by heat-shock method.  
DH5α strain is a versatile E. coli strain that carries the endA1, recA1 and lacZΔM15 
mutations. The endA1 mutation increases plasmid yield, while the recA1 mutation ensures 
insert stability. Blue/white screening is also possible due to the lacZ mutation. 
DH5α and JM109 were used for plasmid amplification and transformation with 
pBlueScript  (pBS)  plasmid for sequencing.  
Carrying the T7 RNA polymerase gene on DE3 (a λ prophage), Rosetta (DE3) pLysS are 
used for protein expression. Protein expression is induced by addition of Isopropyl β-D-1-
thiogalactoèyranoside (IPTG) in liquid medium.  Expression is almost eliminated without 
induction by IPTG. Rosetta (DE3) pLysS are resistant to Chloramphenicol (Cm). 
V.1.2 Yeast Strain 
The yeast strain used is BY5208 MATα ura3-52 his3-Δ200. This strain was provided by the 
National Bio-Resource Project (NBRP) of the MEXT, Japan.  
Encoding for Orotidine 5-phosphate decarboxylase (ODCase), URA3 was mutated in the 
strain used in this experiment. This allows for positive as well as negative selection. ODCase 
is responsible for catalyzation of the transformation of orotidine 5-phosphate to uridylic acid. 
Table 1 Summary of main differences between E. coli and S. cerevisiae 
Escherichia coli Saccharomyces cerevisiae 
Gram-negative; rod-Shape Eukaryotic; round 
2µm-long, 0.5µm diameter  
1.57µm3 of volume 
5µm diameter  523µm3 of volume 
Easily manipulated genetically, 
easily grown 
Easily manipulated genetically, easily 
grown, not weakened by antibiotics 
Incapable of secretion Capable of secretion 
Pathogenic Considered as GRAS by the FDA 
Thin cell wall, low pH tolerance Robust, tough cell walls, wide 
physiochemical tolerance 
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V.1.3 Extremophiles  
T. thermophilus is a thermophilic gram-negative bacterium that grows under aerobical 
conditions (oxygen being the only electron acceptor) from 62°C to 75°C. It has a high growth 
rate, good cell yield, does not require any specific amino acids or vitamins to grow and is 
tolerant to a number of stress conditions. Genome’s information on two different strains is 
available (HB27 and HB8) and both of them are composed of 1.9 Mbp and a mega-plasmid of 
0.23 Mbp. Their GC content is equal to 69%, their coding density to 95%, coding for 
approximately 2,200 proteins (more than 600 having been crystallized). T. thermophilus also 
exhibits the highest transformation frequencies among Thermus, with a velocity of 
40 kb/s/Cell [Averhoff et al., 2010]. Facultative strains of Thermophilus can exhibit 
denitrification under anaerobic conditions [Cava et al. 2009; Jenney et al. 2008].  
Thermus thermophilus (T. thermophilus) is a great source of TEs. Since its discovery in 
1974 [Oshima et al. 1974], interests have been driven by the fact that its macromolecules 
were very well adapted to function at very high temperatures. One good example of such a 
fact is the use of the DNA polymerase, Taq polymerase, of Thermus aquaticus in the 
Polymerase Chain Reaction (PCR). Thermophiles’ natural adaptation was achieved thanks to 
gene mutation, intramolecular recombination, differential gene deletion and horizontal gene 
transfer.  
Thermophiles are a good source of novel catalysts, proteases, starch-converting enzymes 
(such as cyclodextrin glycosyl transferases or glucose isomerase), DNA processing enzymes 
or lipases [Bruins et al., 2001].  
The stabilization of proteins is due to a small number of extra salt bridges, hydrophobic 
interactions, hydrogen bonds [Bruins et al., 2001]. Basic mechanisms of stability are 
summarized in Table 2.  
It is possible to engineer mesophilic enzymes to make them more stable, but the gain is 
usually small. The strategy used is to improve the core packing of the protein. If the stability 
of a protein can be improved, the sensitivity will be lower, as well as the viscosity. The heat 
and mass transfer rate will be improved.  
Table 2 Basic mechanisms of TEs stability [modified from Bruins et al., 2001] 
1 High packing density 
2 Optimum charge patterns 
3 Minimization of accessible 
hydrophobic surface area 
4 Helix stabilization 
5 Subunit assembly 
6 Oligomer formation 
7 Other environmental factors 
 
In this study, T. thermophilus genome was purchased from Harima Riken Institute. 
T. thermophilus HB8 expression plasmids were constructed by “Whole-Cell Project of a 
Model Organism, Thermus thermophilus HB8”, and deposited by Dr. Seiki Kuramitsu, SR 
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System Biology Research Group, RIKEN Harima Institute. Fumarase enzyme gene (fum) 
comes from T. thermophilus HB8 genome. 
Thermococcus kodakaraensis (T. kodakaraensis) is a hyperthermophilic archaeon isolated 
from a solfatara in Japan, whose genome was sequenced [Atomi et al., 2004]. This strain is 
obligate heterotrophic and grows in the presence of sulfur. In this study, it is used for 
obtaining the gene encoding malic enzyme (ME).  
V.2 Plasmids 
V.2.1 Bacterial plasmid 
The plasmid used for FUM expression is pET-11a-FHA and purchased from Harima Riken 
Institute.  
The plasmid used for ME expression is pET21a-ME, already available in our laboratory. 
This plasmid is constructed by ligated ME gene from KOD1 strain with pET21a.  
Both plasmids were introduced into E. coli Rosetta (DE3) pLys strain.  
V.2.2 Yeast Plasmids 
The two different plasmids used in this study are p803 (pNV11) and p804 (derivative of 
p803 that does not contain stuffer cDNA). The plasmids were provided by the National Bio-
Resource Project (NBRP) of the MEXT, Japan. 10 μL of each plasmid were received, with a 
concentration of 0.12 mg/mL for p803 and 0.11 mg/mL for p804.  
Four main types of vectors are available for the transformation of yeasts. Yeast Artificial 
Chromosomes (YACs) are used to clone genes up to 3000 kb. Yeast Episomal Plasmids 
vectors (YEps) are autonomously-replicating high-copy-number vectors. Yeast Integrative 
plasmids vectors (YIps) are non-autonomous but are able to perform a homologous 
recombination, as a single copy. Yeast Centromere plasmid vectors (YCps) are autonomously 
replicating, low copy-number vectors [Hadfield in Johnston, 1994; Mishra and Baranwal in 
Satyanarayana and Kunze, 2009]. In this study, a YEp was chosen, as it has a high copy-
number and, even if it is unstable, should be efficient enough to see if the production of 
fumarase is possible. This vector is composed of a GAP promoter, a DNA stuffer, Apr, 2 μm 
ori, URA3 as well as some restriction enzyme sites. 
 
Figure 1 YEp plasmid map used in this study. This plasmid carries amp resistance to be amplified in E. coli. It also carries 
GAP promoter, for protein production in S. cerevisiae, without induction. P803 contains a stuffer cDNA, while p804 does 
not. 
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V.3 Molecular Biology 
V.3.1 Competent cells 
Theory 
Transformation, the process in which a foreign DNA is imported to a bacteria, was first 
demonstrated by Stanley Cohen Laboratory, in 1973 [Thiemann and Palladino, 2004]. It was 
discovered that plasmids could be incorporated into pre-treated bacterial cells. Once the 
plasmid DNA incorporates inside the bacteria, it can replicate and be expressed. Naturally, 
bacteria do not take up DNA easily. Therefore, bacterial cells need to be treated with, for 
example, an ice-cold solution of CaCl2 as such treatment gives to bacterial cells competence. 
The treated cells are called competent cells and used for bacterial transformation. 
 
Protocol (for 80 x 200 µL E. coli)
i. Pre-culture cells from glycerol stock on LB 
plate (with appropriate selection) 
ii. Inoculation of 1 colony in 5 mL LB, 
incubation overnight at 37°C 
iii. Add 1% cell (v/v) to 200 mL SOB medium 
iv. Incubation at 37°C until OD660 = 0.5 
v. On ice 30 min 
vi. Centrifugation 5,000  rpm in 50 ml tubes 
4°C 5 min, keep cells 
vii. Resuspend cells in 17 mL TB buffer, on 
ice 10 min 
viii. Centrifugation 5,000  rpm 4°C 5 min, keep 
cells 
ix. Resuspend cells in 6 mL TB buffer, on ice 
10 min 
x. Centrifugation 5,000  rpm 4°C 5 min 
xi. Resuspend cells in 4 mL TB buffer and 
0.6 mL DMSO 
xii. Dispense 200 µL in micro tubes 
xiii. Freeze -80°C 
 
V.3.2 Transformation 
Theory 
After cells have been made competent, they can undergo transformation and are therefore 
able to take up foreign DNA. In this study, bacterial cells were transformed by heat shock. 
Yeast transformation was done thanks to the ZYMO RESEARCH Frozen EZ yeast 
transformation kit. Yeast transformation usual process is usually more tedious than bacterial 
transformation [Hinnen et al., 1978; Ito et al., 1983; Gietz et al., 2001, Gellissen et al., 1992] 
Protocol a. Bacterial cells
i. 1 to 10% (v/v) of vector solution to 
competent cells 
ii. On ice 30 min 
iii. 45 sec at 42°C 
iv. On ice 2 min 
v. Mix with 1 mL SOC medium 
vi. 1 hr at 37°C 
vii. Plate 200 µL on appropriate plateb. Yeast cells 
Yeasts transformation with p803-FUM was performed using the ZYMO RESEARCH 
Frozen-EZ yeast transformation kit. Cells were first grown to an OD600 of 1 in a 5mL tube. 
1mL was taken from this culture and pelleted. Competent cells were produced every time 
needed, and not kept at -80°C. Despite the fact that the kit composition is not know, it can be 
guessed that it is based on the LiAC/SS carrier DNA/PEG method demonstrated first by Gietz 
[Gietz and Woods, 2001; Gietz and Schiestl, 2008; Gietz and Schiestl 2008].  
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V.3.3 Polymerase Chain Reaction 
Theory 
The polymerase chain reaction (PCR) allows the amplification of specific DNA fragment 
without using any living organism. It is composed of three steps that can be repeated to form a 
cycle. 
The first step is denaturation, done by heating the DNA template. This allows breakage of 
hydrogen bonds between the complementary two DNA strands, yielding single-stranded DNA 
molecules. The second step is annealing. During this step, the oligonucleotide primers anneal 
to the complementary sequence on the single strands. This temperature depends on the primer 
sequence and is therefore crucial for reaction efficiency. It should be around 5°C lower than 
melting point of primer.  Stable DNA-DNA hydrogen bonds are only formed when the primer 
sequence closely matches the template sequence. The third step is the elongation, done by a 
heat-stable DNA polymerase (e.g. the Taq polymerase, whose optimal temperature is around 
72°C) and polymerase synthesizes a new DNA strand complementary to the template by 
condensing the 5’-phosphate group of the dNTPs with the 3’-hydroxyl group at the end of the 
extending DNA strand. Repeated cycles of those three steps lead to an exponential 
amplification of the sequence of interest [Thiemann and Palladino, 2004; Vosberg et al., 1989, 
Lodisch, 2008].  
Agarose gel electrophoresis, which separates DNA by size, can then be done to check the 
PCR results.  
Protocol 
Primers used in this study were designed from OligoPerfect Designer and provided by Gene 
Design Inc.  
PCR was performed in order to amplify fum from T. thermophilus. Restriction enzymes sites 
were added on both end of the gene, and start codon was modified. Primer sequences are 
listed in Table 3. PCR can also be performed in order to check whether transformants possess 
the target gene or not. Transformants are firstly boiled, in order to break the cell membrane. 
Then, knowing the gene sequence on the plasmid used, PCR can be performed. This is called 
colony PCR. 
 
Table 3 Primers sequences. Modified from information received from GeneDesign. 
Name %GC Size 
[bases] 
Tm 
[°C] 
OD Molecular 
Weight 
Nmol Sequence 
Forward 37.5 32 59.7 3.1 9939 8.0 gaattcaaaaaaatggaataccggattgagcg 
Reverse 72.7 22 67.0 3.2 6648 15.0 gtcgacctacgccccctcgtgg 
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i. Mix MilliQ, primers, DNA of interest 
gene, PrimeStar Premix.  
PCR of fumarase gene Master Mix 
MilliQ 19 µL 
Diluted forward primer 2 µL 
Diluted reverse primer 2 µL 
FUM cDNA 2 µL 
PrimeSTAR Premix 25 µL 
Total 50 µL 
 
 
ii. Run PCR 
 
98°C 30 sec 
98°C 10 sec 
30 cycles   60°C 15 sec 
72°C 1.5 min 
72°C 5 min 
15°C Hold 
 
 
Colony PCR of E. coli cells
i. Pick colony and put in PCR tube with 
20 μL of MilliQ 
ii. Heat 2 min at 98°C 
iii. Spin 2 min 
iv. Take 4 μL of heated sample, add 2 
μL of dNTP, 2 μL of exTaq buffer, 1 μL of 
M13 forward primer, 1 μL of M13 reverse 
primer, 11 μL of MilliQ and 0.1 μL of exTaq 
polymerase. Mix 
v. PCR conditions: ∙98°C for 30 sec ∙ 
98°C for 10sec ∙ 60°C for 30 sec ∙ 72°C for 
1 min 30 sec ∙ 72°C for 5 min ∙ 15°C hold. 
Repeat 30 times.  
 Colony PCR of Yeast cells (adapted from Breeden Laboratory, Hutchinson Cancer Research Center, Seattle) 
i. Prepare Master Mix: 2.5 µL 10x 
buffer; 2.5 µL 2.5 mM dNTPs; 0.5 µL forward 
primer (100 pmol/µL); 0.5 µL reverse primer 
(100pmol/µL); 20 µL MilliQ.  
ii. Pick Colony and resuspend in 26 µL 
of Master Mix.  
iii. Add 0.1 µL of exTaq polymerase 
iv. Perform PCR 
v. PCR conditions: 95°C for 10 min, 
98°C for 30 sec,  60°C for 30 sec,  72°C for 
1 min 30 sec, 72°C for 3 min, 15°C hold; 
repeat cycle 35 times 
 
V.3.4 Agarose gel electrophoresis 
Theory 
Electrophoresis is used to separate molecules by size, conformation or charge. A matrix is 
cast and immersed in a buffer, providing ions to carry a current. The matrices used in this 
project are agarose gels that have a low resolving power, but a large range of separation. As 
DNA is negatively charged, it will migrate through agarose gels with a velocity inversely 
proportional to the log10 of its molecular weight. Circular forms of DNA will migrate in the 
gel differently from the linearized DNA, even if they have the same mass. Undigested 
supercoiled plasmids are meant to migrate quicker than digested plasmids while undigested 
nicked circle plasmids are meant to migrate later than digested plasmids. Examples of such a 
fact can be seen in figure 2. Some factors can affect the mobility of DNA inside the gel, such 
as the agarose concentration, the buffer used, the voltage applied, and the use of ethidium 
bromide (EtBr), which is used as a stain, to be able to visualize DNA under UV light.  
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Figure 2 Examples of migration of fragment of DNA of the same size. Supercoiled plasmids, which are undigested, will 
migrate faster than linear plasmids that are digested. Nicked circle will migrate more slowly.   
 
Electrophoresis was performed in this project to be able to visualize the result of the 
enzymes digestion and PCR. Pictures were taken after 30 to 45 min running time and directly 
after the electrophoresis. 
Protocol 
i. Prepare TAE buffer 
ii. Prepare agarose gels 1% 
iii. Mix sample with 10x loading buffer 
iv. Load 10 µL of sample per well 
v. Load Marker DNA in at least one well 
vi. Run for 40 min 
vii. Take picture 
 
V.3.5 Restriction enzymes 
Theory 
Restriction enzymes (or restriction endonucleases) are found primarily in bacteria and 
archea and are able to digest double-stranded DNA at precisely-located sites, called restriction 
sites. Digesting DNA with a specific enzyme will produce fragments, that all have a precise 
length and a specific nucleotide sequence. There are three different types of restriction 
enzymes. Type I enzymes require ATP as well as S-adenosyl-l-methionine and cleave at sites 
away from recognition site. Type II enzymes often require magnesium and cleave close to or 
within the recognition site. Type III enzymes digest DNA after their recognition site and 
require ATP. Enzymes that digest straight symmetrically across the DNA produce the so-
called “blunt ends”. Digesting DNA in an offset fashion, producing ends with overhanging 
pieces of single-stranded DNA result in the so-called “sticky ends”. Every enzymes used in 
this project create sticky ends and are Type II restriction enzymes. 
Protocol 
i. Mix at least 20 µL of plasmid, 3 µL 
of corresponding buffer, 1 µL of specific 
enzyme, 6 µL of water.  
ii. Incubate at least 2 hrs at 37°C.  
iii. Perform electrophoresis 
 
 
V.3.6 Extraction from gel 
Theory 
DNA product can be extracted from agarose gels after electrophoresis. This is especially 
useful, in order to confirm DNA length of plasmid or fragment before use, without wasting 
part of the sample. Plasmids were retrieved using Illustra GFX PCR DNA purification kit.  
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Protocol (from Illustra GFX kit) 
a. Production of cleared lysate 
i. Centrifugation 1 min, 15,000 rpm up 
to 2 mL of culture, keep cells 
ii. Add 250 μL resuspension buffer, 
vortex 
iii. 250 µL of cell lysis solution 
iv. Invert 4 times 
v. 10 µL of alkaline protease solution 
vi. Invert 4 times 
vii. Incubate 5 min RT 
viii. 350 µL of neutralization solution 
ix. Invert 4 times 
x. Centrifugation 20 min RT 15,000  rpm 
b. Binding of plasmid 
xi. Put mixture into binding column 
 
xii. Centrifugation 1 min RT 15,000 rpm 
xiii. Discard flowthrough 
c. Washing 
xiv. Add 750 µL of wash solution in 
column 
xv. Centrifugation 1min RT 15,000 rpm 
xvi. Discard flowthrough 
xvii. Add 250 µL of wash solution in 
column 
xviii. Centrifugation 5 min RT 15,000  rpm 
d. Elution 
xix. Put column in a sterile tube 
xx. 100 µL of nuclease-free water 
xxi. Centrifugation 1min RT 15,000 rpm 
xxii. Keep flowthrough 
 
V.3.7 Plasmid extraction of large preparation 
In order to retrieve a large amount of plasmid, a large preparation was done. Plasmids were 
retrieved without any kit.  
Protocol 
i. Centrifuge overnight culture (100 mL) 
of transformed bacteria 
ii. Resuspend in 5 mL Solution I 
iii. Add 10 mL Solution II 
iv. Incubate at RT 5min 
v. Add 5 mL Solution III, centrifugation 
10 min, keep SN 
vi. Phenol-chloroform purification 
vii. Ethanol precipitation 
viii. Add 500 µL MilliQ 
ix. Add 5 µL RNase solution 
x. Incubation 1 hr at 37°C 
xi. Phenol-chloroform purification 
xii. PEG precipitation 
 
V.3.8 Sequencing 
Theory  
pBlueScript (pBS) is a phagemid that is commercially available. It includes a polylinker 
sequence located into the LacZ gene and an amp resistance. This allows the selection of 
transformed bacteria thanks to Ampicillin as well as blue/white screening. IPTG and X-gal 
are added on the LB plate. If the DNA of interest was correctly integrated into pBS, the LacZ 
gene will be disrupted and the colony will appear white. On the other hand, the colony will 
appear blue if the LacZ gene is still intact [Alting-Mees et al., 1989; Short et al., 1988].  
pBlueScript phagemid needs first to be digested with a blunt end restriction enzyme. Here, 
EcoRV was used. The digested vector needs to be purified after, either by gel electrophoresis 
or by phenol-chloroform purification followed by ethanol precipitation. To prevent self-
ligation, the plasmid is treated with calf intestinal alkaline phosphatase (CIAP), to be 
dephosphorylated. In order for CIAP not to strip the 5’ phosphates off of the DNA insert, it 
needs to be inactivated. This is done by phenol-chloroform purification, followed by ethanol 
precipitation. The prepared pBS can then be ligated with the prepared insert. This insert, after 
having been extracted from gel, needs to be purified by ethanol precipitation, followed by a 
T4 polynucleotide kinase treatment. This enzyme will phosphorylate the insert, and a 
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phosphate group is added to the 5’ end. After incubation, phenol-chloroform purification and 
ethanol precipitation can be done in order to separate the DNA of interest from the mixture of 
kinase, rATP and buffer. 
Ligation of the modified fumarase gene with pBS was performed in order to sequence the 
gene with the Sanger method. Ligation was performed using the Ligation Mix 2x and 
incubation at 16°C for at least 2 hours. Ligated vectors were then used for the transformation 
of E.coli cells, by heat shock. Cells were then incubated overnight at 37°C. Growth and color 
were checked after at least 20 hours of incubation. pBS was prepared using EcoRV and 
therefore digested in a blunt end manner. X-gal and IPTG were added on agar plates before 
plating bacteria as indicator of insertion of fumarase gene. IPTG is an inducer for β-
galactosidase and X-gal is substrate of this enzyme. Only when fumarase gene is not inserted 
into pBS, β-galactosidase is expressed. As a result, X-gal was degraded and blue color 
appeared.  
protocols a. pBS preparation protocol
i. Mix  40 μL pBS extracted , 10 μL 
10x H buffer, 2 μL EcoRV, 48 μL MilliQ 
ii. Incubation ON at 37°C 
iii. Phenol-chloroform purification 
iv. Ethanol precipitation 
v. Add 43 μL of MilliQ 
vi. Mix with 2 μL of CIAP and 5 μL of 
10x alkaline phosphate buffer 
vii. Incubation CIAP 15 min at 50°C 
viii. Phenol-chloroform purification 
ix. Ethanol precipitation 
x. Add 30 μL of MilliQ 
 b. T4 kinase treatment protocol
i. Gel electrophoresis and extraction of 
PCR  
ii. Ethanol precipitation 
iii. Add 10 μL of MilliQ water 
iv. Add 75 μL of denaturation buffer for 
kinase treatment 
v. Heat 90°C for 2 min 
vi. Put on ice for 3 min 
vii. Add: -10 μL 10x blunt end buffer, -10 
μL 10 μM rATP, -2 μL T4 kinase, -3 μL 
MilliQ  
viii. Incubation 1 hr at 37°C 
ix. Heat at 90°C for 3 min 
x. Phenol/chloroform purification 
xi. Ethanol purification 
xii. Add 20 μL of MilliQ water c. blue and white screening 
pBS ligated with the gene of interest can be amplified by E. coli transformants. The cells 
having correctly integrated the gene of interest on the plasmid will appear white. The cells 
with an empty plasmid will appear blue. Cells that have not been correctly transformed should 
not grow, due to amp in the medium. White colonies can then be used for colony PCR. 
Colonies carrying the gene of interest can then be grown into a bigger flask, and plasmid can 
be extracted in order to sequence the gene of interest. d. BigDye sequencing 
The BigDye Terminator v3.1 Cycle Sequencing Kit was used for FUM gene sequencing.  
i. Extract plasmid from bacteria 
ii. Prepare PCR reaction mix 
iii. Thermal Cycling 96°C 1 min, 96°C 10 
sec, 50°C 5 sec, 60°C 4 min, 4°C hold, 25 
cycles 
iv. Add 5 µL 125 mM EDTA (pH8.0) to 
each PCR tube 
v. Add 60 µL of 99.5% Ethanol  
vi. Mix, centrifuge 10min 15,000 rpm 
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vii. Remove SN, rinse with 30 µL of 70% 
Ethanol 
viii. Centrifuge 5 min 15,000 rpm 
ix. Remove SN, dry under vacuum, wrap 
tubes with aluminium foil 
x. Suspend in 15µL Hi-Dye formamide  
xi. Boil 2 min, cool on ice 
xii. Transfer to sequencer plate 
PCR reaction Mix 
BigDye Terminator  
Ready Reaction Mix 3µL 
Template * 
Primer 3.2pmol 
Distilled Water Up to 15µL 
 15µL 
 
 
Template DNA  
Single-stranded DNA 25-50ng 
Double stranded DNA 150-300ng 
PCR products (100-
200bp) 
1-3ng 
(200-500bp) 3-10ng 
(500-1000bp) 5-20ng 
(1000-2000bp) 10-40ng 
(>2000bp) 20-50ng 
 
V.3.9 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Theory 
SDS-PAGE allows the separation of protein in function of their size. As proteins have 
tertiary and quaternary structure, the first step is linearization by using SDS as a denaturing 
agent. SDS breaks up hydrophilic areas and coats proteins with negative charges. The second 
step is electrophoresis in a gel-like matrix. Small protein will migrate faster than big protein 
through gel. Denaturated proteins are negatively charged and will therefore move toward the 
plus size. The last part is to stain the gel, in order to visualize the proteins.  
The gel used in this study is composed of two parts: separating gel and stacking gel. 
Stacking gels is made of large pores, while separating gel is made of small pores, high salt 
concentration and high pH.   
Protocol 
Table 4 Gels recipe for SDS-PAGE (for 2 gels) 
 Separating gel (15%) Stacking gel 
Solution A 9 mL 900 µL 
Solution B 4.5 mL 0 mL 
Solution C 0 mL 1.5 mL 
MilliQ water 4.5 mL 3.6 mL 
Ammonium peroxodisulfate ½  small spoon ½ small spoon 
10%SDS 180 µL 60 µL 
TEMED 10 µL 10 µL 
 
Sample preparation 
i. Mix protein extract with same amount 
of SDS sample buffer 
ii. Boil 3 min 
iii. Load on gel, up to 20 µL.  
iv. Run gel at 180 V for approximately 
1 hr.  
v. Stain with Coomassie Brilliant Blue 
20 min at RT.  
vi. Unstain with unstaining solution ON  
vii. Take picture 
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V.3.10 Protein extraction 
Proteins can be extracted from cells in order to perform SDS-PAGE or enzyme assay. 
Depending on the microorganism, the extraction process will be different. In this study, 
proteins were extracted from bacteria cells as well as yeasts cells. Sonication was used to 
extract proteins from bacterial cells. Post-alkaline extraction, glass beads as well as DTT 
treatment were performed to extract proteins from yeast cells. 
a. Sonication 
i. Harvest culture by centrifugation at 
maximum speed, 4°C, 10 min 
ii. Resuspend in buffer (Phosphate buffer 
salines (PBS) or 0.2%Phosphate buffer) 
iii. Divide sample to get 10 mL per tube 
at most 
iv. Sonication 3 min (10 sec sonication 
and 20 sec wait, on ice) 
v. Centrifugation 10 min 4°C 
 
b. Post-alkaline extraction (PAE) (modified from Kushnirov et al., 2000) 
i. Overnight culture or until OD600 = 2.5 
(~2.3mg of wet weight) 
ii. Harvest by centrifugation 
iii. Resuspension un 100 µL MilliQ 
iv. Add 100 µL 0.2M NaOH 
v. Incubation 5min at RT 
vi. Harvest by centrifugation 
vii. Resuspend in 50 µL SDS Sample 
buffer 
viii. Boil 3 min 
ix. Pellet 
x. Load 6 µL SN¨  
c. Glass beads shaking (GB) 
Glass beads protocol was modified from Wakenyaku Co. LTD. Minibeads beater 3110BX 
Handling tips. In principle, 2 to 5 min of glass beads shaking should be enough to recover 
90% of proteins from cells.  
Resuspended cells at a concentration maximum of 400 mg/mL were shaken for 1 minute 
with 0.5 mm glass beads. This sample was then kept on ice 1 min. This was repeated up to 4 
times.  
d. Glass beads – DTT (GB-DTT) (modified from LeBel et al., in Yeast Protocols, 
p. 300) 
This protein extraction protocol is designed to retrieve low-abundance enzymes, such as 
telomerases.  
Protocol 
i. Pick a colony and inoculate in 
appropriate medium ON at 30°C.  
ii. Centrifuge 8,000 rpm 4°C 5 min.  
iii. Rinse with ice-cold MilliQ 1 mL.  
iv. Centrifuge 4°C 8,000 rpm 5 min.  
v. Rinse with ice-cold TMG/NaCl buffer 
2.5 mL.  
vi. Centrifuge 4°C 8,000 rpm 5 min 
vii. Resuspend in 750µL TMG/NaCl/DTT 
buffer, transfer in micro tube for glass beads.  
viii. Add beads. 
ix. Vortex 30 sec. Let stand 30 sec on 
ice. Repeat 25 times.  
x. Remove liquid part, transfer in new 
micro tube. 
xi. Centrifugation 15 min, 15,000 rpm 4°C 
xii. Transfer SN in new micro tube 
xiii. Centrifuge 30 min 4°C 15,000 rpm 
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V.4 Enzyme experiments 
V.4.1 Spectrophotometry 
Light absorbed by a sample can be measured by a spectrophotometer. Intensity of light 
through a liquid sample at a specific wavelength is measured. This is then converted to an 
absorbance value, expressed as 𝐴 = 𝑙𝑜𝑔 𝐼0
𝐼
, where I is the intensity of light through the sample 
and I0 is the intensity of light through the blank sample (or without any sample).  
V.4.2 Enzyme assay 
Theory 
Enzyme activity was first tested in vitro, by spectrophotometer. As all the enzymes produced 
in this study are TEs, protein extract from cells were first heated at 70°C for 20 min, in order 
to inactivate hosts proteins. Samples were then centrifuged and SN kept to be used at 70°C. 
Two different enzyme assays were done, to check FUM activity. The first one, fumarase assay, 
was done by monitoring fumarate consumption or production. The second one was done by 
coupling FUM with ME, in order to be able to monitor NADP+ reduction to NADPH. ME 
converts LMA to pyruvate by using NADP+ as a cofactor.  
 
Figure 3 Coupled enzymes assay equation used in this study. NADP+ conversion to NADPH can be monitored at 340 nm.  
 
Protocol a. Fumarase assay (modified from sigma Aldrich) 
i. Resuspend ON culture of cells over-
expressing FUM in potassium phosphate buffer 
to get 100 mg/mL of cells 
ii. Extract proteins 
iii. Heat protein extract at 70°C for 20 
min 
iv. Centrifugation 10 min 8,000  rpm 
v. Stabilize spectrophotometer for 240 nm 
and heat it at 70°C 
vi. In spectrophotometer glass cuvette, mix 
50 µL of FUM protein extract, 100 µL of 
HEPES-NaOH pH 8.0 0.5M; 825 µL of MilliQ 
vii. Autozero, wait 3 min (or until stable) 
viii. Add 25 µL of substrate (fumaric acid 
50mM or L-malic acid 50mM) 
ix. Record absorbance over 3 min 
 b. Coupled enzymes assay  
i. Resuspend ON culture of cells over-
expressing FUM in potassium phosphate buffer 
to get 100 mg/mL of cells 
ii. Resuspend ON culture of cells over-
expressing ME in potassium phosphate buffer 
to get 100 mg/mL of cells 
iii. Extract proteins from both samples 
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iv. Heat protein extracts at 70°C for  20 
min 
v. Centrifugation 10min 8,000 rpm 
vi. Heat Spectrophotometer at 70°C and 
stabilize it at 340 nm 
vii. In spectrophotometer glass cuvette, mix 
800µL of ME extract; 50 µL of FUM extract; 
100 µL of HEPES-NaOH pH8.0 0.5M; 1 µL 
MnCL2 50 mM; 10 µL NADP+ 10 mM; 14 µL 
MilliQ 
viii. Autozero, wait 3min (or until stable) 
ix. Add 25 µL of substrate (Fumaric acid 
50 mM) 
x. Record absorbance over 3min 
Before recording FUM activity, ME activity 
should be checked. Therefore, the mix 
composition will be changed. No FUM extract 
and fumaric acid should be added, but 64 µL 
of MilliQ and 2 5µL of 50 mM LMA should 
be used instead 
V.4.3 Bradford protein assay 
Theory 
The Bradford protein assay is used to quantify the concentration of a protein in a solution. It 
involves the binding of Coomassie Brilliant Blue to protein. The red form of Coomassie 
Brilliant Blue is converted to the blue form after binding with the protein. This binding can be 
monitored at 595nm, as it increases the absorption maximum. This rapid process has a good 
color stability (approximately 1 hour) [Bradford, 1976].In order to quantify correctly the 
amount of protein in the sample, the assay can be done with a known concentration from 
another protein. In this study, bovine serum albumin (BSA) was used as a standard. After 
calculating the standard curve, the unknown concentration can be found. Standard values used 
can be found in Table 5. 
Protocol 
a. Protein standard 
Table 5 Protein standard for Bradford assay 
Sample 
number 
BSA concentration [mg] 2mg/mL BSA solution 
[µL] 
MilliQ [µL] 
1 0 0 20 
2 0.5 5 15 
3 1 10 10 
4 1.5 15 5 
5 2 20 0 
b. Sample assay 
 
i. Take 20 µL of protein sample to 
analyze as sample 6 
ii. Add 800 µL MilliQ to every sample 
iii. Add 200 µL BioRad Protein Assay 
iv. Vortex 
v. Wait 10 min 
vi. Check absorption at 595 nm; sample 
1 is blank.  
vii. Record absorbance for sample 2 to 5 
as well as unknown concentration of protein
V.4.4 L-Malic acid detection assay 
Before performing High Performance Liquid Chromatography (HPLC) experiment, it 
appeared important to check the detection limit of HPLC instrument with the product 
expected in this study. This was done in order to know if a negative result comes from the fact 
that the product was not formed or not detected. 
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Protocol 
i. Prepare solution of 300 mM of LMA 
in water.  
ii. Make dilution of this solution to get 
150 mM, 100 mM, 50 mM, 30 mM and 
25mM  
iii. Make serial dilutions of those solutions 
(4 dilutions by 10).  
iv. Analyze by HPLC.  
Solution range: from 300 mM to 0.0025 mM. 
The detection limit is reached when the 
sample cannot be detected by HPLC anymore. 
 
 
V.4.5 Fumaric acid solubility assay 
In order to know more precisely the behavior of FA at 70°C, its solubility was checked. It 
appeared that at RT, it was not possible to dissolve 100 mM of FA. Therefore, the highest 
concentration of solution used in this study was 50 mM. FA solubility was then calculated for 
8 different temperatures. 
 
Protocol 
i. In PCR tube, put at least 2 mg of 
fumaric acid.  
ii. Add 200µL of water.  
iii. Incubate for 24 hrs at different 
temperatures. Here: 50°C, 51.5°C, 54.5°C, 
58.9°C, 64.4°C, 69.0°C, 73.0°C 
iv. Repeat with at least 5mg and 10 mg 
of FA.  
v. Analyze concentration by HPLC.  
Only the highest concentration over the three 
experiment is shown in the result.  
 
V.4.5 Bioinformatics tools  
 a. BLAST 
Blast analysis of the fumarase gene from T. thermophilus HB8 was performed. Analysis of 
similarity was performed using T-coffee program. T-coffee is a multiple alignment sequence 
alignment program that uses ClustalW [Notredame et al., 2008].   b. ExPASy calculation 
The protein of interest, FUM, was analyzed by ExPASy [Gasteiger 2003].  
V.4.6 Whole cell experiment Theory 
Synthetic Metabolic Engineering methods were performed by the so-called whole cell 
experiment. As explained earlier, SME is based on the expression of TEs in mesophilic hosts 
[Restiawaty et al., 2011]. Indigenous enzymes are inactivated by heating hosts cells at 70°C. 
By doing so, it is believed that no side reactions should occur and that the cell membrane of 
the host is partially disrupted. The first step of SME is the transformation of the host by a 
plasmid carrying the enzyme of interest. After expression of the target enzyme in step 2, cells 
are heated at 70°C. Due to the heat treatment, substrate can go through the damaged cell 
membrane, and conversion can happen.  
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Figure 4 Summary of Synthetic Metabolic Engineering. During the first step, cells are transformed with a plasmid 
carrying the target thermo-stable gene. After transformation, the protein is overexpressed in the cell. Cells are then 
heated at 70°C, in order to inactivate the mesophilic enzymes and get no undesired side reactions. 
 
Protocol 
i. From plate, inoculate 5 mL tube (with 
appropriate selection). Incubate 8 hours. 
ii. Inoculate flask 100 mL of medium, 
incubate 2 hours at 37°C 
iii. Add inducer (if needed) 
iv. Incubate overnight 
v. Divide in 50 mL centrifuge tube, 
centrifuge 8,000  rpm, 10min 
vi. Keep cells, resuspend to get 400 
mg/mL in appropriate buffer 
vii. Divide in microtubes 15 µL of cells, 
105 µL of MilliQ 
viii. Incubate at 70°C 20 min 
ix. Add cofactor and substrate up to 30 
µL 
x. Incubate at 70°C.  
xi. stop the reaction by adding 150 μL of 
ice-cold phosphate buffer and keeping samples 
on ice 
xii. Centrifuge 5 min, 5,000  rpm 4°C, 
keep SN 
xiii. Load 100 µL of SN into HPLC tube
V.4.7 High Performance Liquid Chromatography (HPLC) 
Theory 
HPLC is used to identify, quantify and/or purify particles. An adsorbent, called stationary 
phase, is packed in a column and eluted. The sample which contains the particle to be 
analyzed is washed through the column thanks to the eluting liquid (called mobile phase). 
Components adsorbed weakly on the surface of the stationary phase will travel faster than the 
ones strongly adsorbed [Lindsay and Barnes, 1992]. There are two variants in use in HPLC, 
known as the normal phase HPLC and reversed phase HPLC. Normal phase is used for non-
polar solvent, while reversed phase is used for polar solvent. In this study, only reversed 
phase HPLC was used. The column silica surface has long hydrocarbon chains attached to it. 
Non-polar compounds will therefore pass more slowly through the column than polar ones.  
Protocol Mobile phase preparation 
Solvent used in this study is 0.1% phosphate solution. 0.1% Phosphoric acid is mixed with 
deionized water, and filtered through a hydrophilic filter. This solution is kept at RT. 
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Sample preparation 
Samples to be analyzed were first centrifuged for 5 min at 8,000 rpm. 100 µL of SN were 
loaded to the HPLC tubes to be analyzed. Instruments preparation 
The column used in this study is Cosmosil packed column, from Nacalai Tesque (Code 
number: 38145-21, size: 4.6x250 mm; 5C18-AR-II; type: water; manufacturer number: 
K54659). After 25 min of purge, and 1 hr of washing with water, the column was inserted in 
the instrument and filled with water. The column was then washed for another hour with 
water. Mobile phase was then changed to 0.1% phosphate buffer, and it was pumped through 
the column until stabilization of detector (or at least 30 min). Analyze was then started. After 
analyze of every sample, column and instrument were washed for 1 hr at least.   HPLC Instruments parameters [Detector parameters modified from Prezecki et al., 2005] 
Data Acquisition 
LC Stop time: 12 min 
Sampling: 500 msec 
Start time: 0.00 min 
End time: 12.00 min 
Pump 
Mode: Isocratic Flow 
Pump A Flow: 0.7000 mL/min 
Pump B Flow: 0.000 mL/min 
Configured pumps: Pump a and B LC20-AD 
Pressure limits (Pump A and B): Maximum 
20.0 MPa, Minimum 0.0 MPa 
Detector UV/VIS 
Model: SPD-20A 
Lamp: D2 
Polarity: + 
Response: 1.0 sec 
Cell temperature: 48°C 
Wavelength: 210 nm 
Output intensity unit: Volt 
Auxiliary Range: 1.0 AU/V 
Recorder range: 0.0100 
Column oven 
Model: CTO-20A 
Oven temperature: 50°C 
Maximum temperature: 85°C 
Controller 
Model: CBM-20A 
Autosampler 
Model: SIL-20A 
Sample Rack: Rack 1.5 mL 105 vials 
Rinsing volume: 200 µL 
Needle Stroke: 52 mm 
Control Vial Needle Stroke: 52mm 
Rinsing speed: 35 µL/sec 
Sampling speed: 15 µL/sec 
Purge time: 25.0 min 
Rinse mode: Before and after aspiration 
 
V.5 Medium 
All media were autoclaved before use 
V.5.1 Bacteria culture 
LB Broth 
2% (w/v) LB broth 
 2% (w/v) Agar (if solid 
medium) 
 Antibiotics (if 
needed) 
 Water 
 
 
Bacteria cells were replated every month 
on a new plate. After 12 hours growth, 
plates were kept at +4°C. 
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V.5.2 Yeasts culture 
 
YP Broth (from Romanos et al., 1995) 
Yeast Extract 1% (w/v) 
Bacto peptone 2% (w/v) 
Water 1L 
 
 
 
YEPD (from Curran et al. in Xiao et 
al.) 
Yeast Extract 1% 
Tryptone 2% 
Glucose 2% 
Agar ( if 
needed) 
2% 
Water  
Selection Medium SD+HIS 
Yeast Nitrogen without 
amino acids 
6.7 gr 
Glucose 20 gr 
Agar (if needed) 20 gr 
Histidine 0.02 gr 
Water 1L 
 
Table 6 Summary of yeasts media and their composition 
Medium name Ingredients Per liter of water Modified from 
YEPD Yeast Extract 
Tryptone 
Glucose 
Agar 
Water (to 1L) 
10g 
20g 
20g 
20g 
Curran et al. in 
Xiao et al. 
YP broth Yeast extract 
Bacto Tryptone 
Water (1L) 
10g 
20g 
Romanos et al., 
1997 
 
Yeasts cells stored at +4°C and received from NBRP were taken and put (approximately 
40µL) into one tube of YP broth and on one YEPD plate, without adding any antibiotics. 
After 3 days of incubation at 30°C, growth could be seen in the plate as well as in the tube. 
One colony from the plate were picked and replated in another YEPD plate. This ensures that 
the cells that will be picked for future work will come from one colony and therefore one 
clone. After three days incubation, the plate was put at +4°C for future uses. 
After transformation, yeasts were grown on selection medium SD+HIS. This ensures that 
only the cells that still carry the plasmid of interest can grow.  
Yeast cells were replated every month on a new plate. After 60 hours incubation at +30°C, 
cells were kept at +4°C.  
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V.6 Basic Protocols 
V.6.1 Ethanol Precipitation 
i. Add 3 M Sodium Acetate 1/10 
ii. Add 100% ethanol 2.5x 
iii. Store on ice 30min 
iv. Centrifugation 15 min, discard SN 
v. Add 70% ethanol 2.5x 
vi. Centrifugation 10 min, discard SN 
vii. Dry at 37°C 
V.6.2 Phenol/Chloroform purification 
i. Add phenol ½Voltot 
ii. Add chlofororm (IAA) ½ Voltot 
iii. shake 1 hr at RT 
iv. Centrifugation 10 min 
v. Transfer supernatant to a new tube 
V.6.3 Polymerase Chain Reaction for modification of fumarase 
Mix :  19 μL of MilliQ water, 2 μL  of diluted forward primer, 2 μL  of diluted reverse 
primer, 2 μL  of fumarase gene, 25 μL  of PrimeSTAR Premix.  
Run : ∙98°C for 30 sec ∙ 98°C for 10 sec ∙ 60°C for 15 sec ∙ 72°C for 1 min 30 sec ∙ 72°C for 
5 min ∙ 15°C hold. Repeat 30 times. 
V.6.4 PEG Precipitation 
i. Add 500 µL of 13% PEG 
ii. Incubation on ice 1 hour 
iii. Centrifugation 15 min 
iv. Keep pellet 
v. Rinse with 70% EtOH 1 mL 
vi. Centrifugation 15,000  rpm 5 min, 
remove SN 
vii. Dry in vacuum 1 hr 
viii. Resuspend in 100 µL MillQ 
 
V.7 Solutions 
V.7.1 SOC medium 
Tryptone 2%(w/v) 
Yeast Extract 0.5% (w/v) 
NaCl 10 mM 
KCl 2.5 mM 
MgCl2 10 mM  
MgSO4 10 mM 
Glucose 20 mM 
Water  
 
V.7.2 TB buffer 1Liter 
PIPES 3 g 
CaCL2·2H2O 2.2 g 
KCl                                    16.6 g 
MnCl2·4H2O 10.9 g 
Water 1 L 
  
Adjust pH to 6.7 with KOH, filter 
sterilize 
V.7.3 TAE buffer 
Tris 40 mM 
Acetic acid 20 mM 
EDTA 1 mM 
In water  
V.7.4 Agarose Gel (1%) (for 150mL) 
Agarose S 1% (w/v) 
EtBr added after 
cooling 
10 µL 
In TAE buffer  
 
V.7 5 Solution I (for DNA extraction) 
Glucose 50 mM 
Tris-HCl pH 8.0 25 mM 
EDTA pH 8.0 10 mM 
Water  
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V.7.6 Solution II (20mL) 
NaOH 0.16 g 
10%SDS 2 mL 
MilliQ Up to 20 mL 
 
V.7.7 Solution III 
Potassium Acetate 3 M 
Acetic acid (fold) 5 M 
Water  
 
V.7.8 SDS-PAGE Sample buffer 
0.5M Tris-CL (pH 6.9) 125 µL 
10% SDS 200 µL 
2-mercaptoethanol 50 µL 
BPB solution 100 µL 
 475 µL 
 
V.7. 9 Bromophenol blue (BPB 
solution) 
0.5M Tris-CL 
(pH6.8) 
1.25 mL 
Bromophenol Blue 5 mg 
Glycerol 7 mL 
Deionized water 1.75 mL 
 10 mL 
V.7.10 Solution A (30% acrylamide) 
acrylamide 29.2 g 
N,N’-methylen bis-
acrylamide 
0.8 g 
Water Up to 100mL 
 
 
V.7.11 Solution B (1.5 M Tris-HCl 
buffer ; adjust pH to 8.8) 
Tris 18.2 g 
Water 100 mL 
 
 
V.7.12 Solution C (0.5M Tris-HCl 
buffer. Adjust pH to 6.8) 
Tris 6.1 g 
Water 100 mL 
 
 
V.7.13 TMG/NaCl buffer 
Tric-HCl pH 8.0 10 mM 
MgCl2 0.1 mM 
NaCl 200 mM 
water  
 
V.7.14 TMG/NaCl/DTT buffer 
DTT 0.1 mM 
TMG/NaCL 
Buffer 
 
 
V.7.15 10x Phosphate-buffered 
saline (PBS) 
NaCl 8 g 
KCl 0.2 g 
Na2HPO4°12H2O 2.9 g 
KH2PO4 0.2 g 
Water 100mL 
 
V.7.16 Ampicillin 
100 mg/mL of ampicillin in MilliQ, filter 
sterilize, freeze at -20°C. Final concentration in 
medium: 200 mg/L 
V.7.17 IPTG 
0.2M IPTG in MilliQ, filter sterilize, freeze at 
-20°C. Final concentration in medium: 0.2mM 
V.7.18 Cm 
34 mg/mL of Cm in EtOH, freeze at -20°C. 
Final concentration in medium 34 mg/L 
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VI. Results 
 
Two plasmids were given by the NBRP, p803 and p804. As it can be seen on the map in 
figure 1, p803 and p804 plasmids are really similar except that p803 contains stuffer DNA on 
the downstream of GAP promoter. The both carry two selections markers, an amp resistance 
as well as URA3. The constitutive GAP promoter and terminator are present on the plasmid 
and, therefore, there is no need of induction to express the protein of interest. It first appeared 
important to check whether restriction sites representing on the given plasmid maps are 
available or not, in order to remove the stuffer DNA and insert FUM DNA. 
Part 1: Enzyme digestion 
Table 7 List of enzymes on pnv11 and NEBcutter digestor results 
Enzyme name Number of 
digestion in FUM 
cDNA 
BstXI 4 
EcoRI 0 
NotI 1 
Sal1 0 
XbaI 0 
XhoI 1 
 
 
Figure 5 Electrophoresis of large preparation of plasmids p803 and p804, with XbaI or XhoI. Lanes: 1: p803 digested 
with XbaI; 2: p803 digested with XhoI; 3: p804 digested with XbaI; 4: p804 digested with XhoI; 5: p803 undigested; 
6: p804 undigested; L: 2-log DNA ladder 10 µL 
 
As it can be seen in Table 6, only 6 enzymes sites are present on p803 and p804. Among 
those enzymes, only 3 do not digest fum [results found with Nebcutter, Vincze et al., 2003].  
It was therefore decided to focus only on EcoRI, SalI, XbaI, and XhoI enzymes. A larger 
preparation of the plasmids was done, in order to make digestions with the targeted restriction 
3.0 Kb 
 
1.0Kb 
1   2  3  4   L 5  6           L 
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enzymes. This step was performed using E. coli JM109 cells transformed with the plasmids 
and selected thanks to amp resistance marker. After preparation of the plasmids, digestion 
with the targeted restriction enzymes was carried out, and digestion was confirmed by 
electrophoresis. The control undigested plasmids were also put on the gel.  
 Figure 5 shows the result of digestion with XbaI or XhoI. Different from given information, 
digestion with XbaI brings two size of bands (lanes 1 and 3). On the other hand, digestion 
with XhoI brings expected size of bands (lanes 2 and 4). As expected, the undigested control 
plasmids (lanes 5 and 6) migrate further than the digested plasmids (lanes 2 and 4) as 
undigested plasmids are supercoiled, while digested plasmids are linearized.  
 
 
Figure 6  p803 and p804 digested with EcoRI. Lanes: L: 2-log DNA ladder, 1: p803 digested with EcoRI, 2: p804 digested 
with EcoRI   The waiting time for the digestion was around 5 hours. 1: L: 2log DNA ladder 10µL, 1: p803 digested with 
EcoRI; 2: p804 digested with EcoRI; 3: p803 digested with EcoRI and SalI; 4: p804 digested with EcoRI and SalI  
 
Subsequently, digestion was performed with EcoRI. Two EcoRI sites were present on the 
given plasmids map (figure 1), with one between brackets. It so appeared important to first 
test if the plasmids were digested once or twice with this enzyme. The results in figure 6 show 
that EcoRI digests the plasmids only once. This was also different from given information. 
  
 
 L             1              2       L 
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1.0Kb 
 24 
 
 
Figure 7 p803 and p804 digested with EcoRI and SalI. Lanes: L : 2log DNA ladder 10 µL; 1: p803 digested with EcoRI and 
SalI, 2: p804 digested with EcoRI and SalI. A light band can be seen in well 1, representing the cDNA stuffer. The waiting 
time for the digestion was around 5 hrs. 
 
 
Figure 8 p803 digestion with EcoRI and SalI.  A light band can be seen in well 1, representing the stuffer DNA. Plasmid 
p803 was then extracted from this gel and kept at -20°C; Lane : L: 2-log ladder 10μL; 1: Plasmid digested with EcoRI and 
SalI 30 μL and 3 μL of dye 
 
Digestion with EcoRI and SalI was also carried out and result showed that this combination 
of enzymes enables to remove the stuffer DNA from p803. Two digestion were performed 
and can be seen in figure 7 and 8. Therefore, EcoRI and SalI were chosen as enzymes used for 
following plasmid construction.  
 
      L     1            L  
       L       1              2      L   
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Gene modification 
 
Figure 9 S. cerevisiae RBS consensus sequence, created with seqLogo. The sequences used were retrieved from UCSC 
Table browser, with the genome of S. cerevisiae, assembled in June 2008, track: SGC genes strand + and entire genome 
 
The gene available commercially from T. thermophilus was already engineered to be 
produced in bacterial cells more effectively. This sequence, available in the laboratory, can be 
seen in appendix. It starts with a “GTG” start codon and ends with a TAG stop codon. As 
codon bias is known to play a role in gene expression [Sharp et al,. 1986], it was decided to 
focus on the upstream part of the gene sequence as well as the start codon itself. Figure 9 was 
therefore created. This figure shows the ribosome binding site (RBS of S. cerevisiae) (the 
initiation codon as well as a few bases upstream). 
 
 
Figure 10 Fumarase gene after PCR with PrimeStar premix. 20 μL loaded in each well, 10 μL of 2-log ladder was used. 
 
According to this consensus sequence, FUM gene of T. thermophilus HB8 was amplified 
with upstream sequence modification using the primers received from GeneDesign Inc. The 
primers were also designed to add EcoRI site to 5’ terminal and SalI site to 3’ terminal of 
FUM gene, respectively. Primers were designed thanks to OligoPerfect Designer webtool. 
Dilutions of the primers received were completed in order to obtain 0.2-0.3 μM of primers 
(final concentration). PCR was performed using the PrimeSTAR HS (Premix) to amplify the 
gene and make the correct change in the sequence. The amplification of modified fum gene 
was confirmed by electrophoresis. As shown in figure 10, the band corresponding to expected 
3.0 Kb 
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size of modified fum (1,400 bp) was observed. Amplified fragment was then inserted into pBS 
plasmid by following procedure. pBS plasmid was digested with EcoRV and treated with 
CIAP. The DNA insert was treated with T4 kinase. Ligation of the treated DNA insert and 
pBS was carried out with Ligation Mix. The ligated plasmid (pBS-FUM) was transformed to 
E. coli cells by heat shock treatment. 
Several trials of pBS preparation and ligation were carried out. As the PCR product of FUM 
gene was too concentrated and it was hard to find the good proportion between FUM and pBS 
vector no colonies were obtained at first after the ligation of fum with pBS. A good ration 
between pBS and the gene of interest is important. Generally, 0.15 pmol of insert and 
0.03 pmol of pBS vector are needed for the ligation to happen. By measuring the absorbance 
of DNA solution using spectrophotometer, the amount of μL needed can be calculated. The 
length of the gene being known, the pg of DNA needed can be calculated. After several trials, I 
succeeded to obtain transformants. 9 colonies were obtained, out of them 3 were blue. 
Sequencing of gene modifications 
Ligation of the modified gene with pBS is checked by blue/white screening after 
transformation of competent bacteria.   
8 colonies were picked and checked by colony PCR with the usual protocol. As shown in figure 
11, colonies 1 to 9 have integrated fum that is approximately 1,500 bp length. This length is 
slightly longer than the expected length from sequence of fum (ca. 1,400 bp). As it appeared 
that a large quantity was loaded on the gels, a shift in the gene length could be occurred. 
However, the shift seen here seems somehow too large. It could be interesting to make a 
further analysis on this result. The insert found here could be purified from the gel and then 
digested with EcoRI and SalI. The length of the digested DNA could then be checked, in 
order to see if the insert found is really fumarase. 
 
 
Figure 11 Colony PCR of pBS ligation with fum. Lanes: L: 2-log ladder 6μL; C1-15: Colony PCR 20 μL and 2 μL of dye.  
Colonies 1-9 come from one preparation of pBS, colonies 10-15 come from another preparation of pBS 
 
 
  L  C1  C2  C3   C4  C5  C6  C7 L    C9 C10C11C12C13C14C15  L 
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Figure 12 Overlapping region of sequenced gene. Two primers were used, separately, to sequence the gene of interest. 
As ligation with pBS was done, the gene was sequenced as follows. From colony 1 and 7, 
pBS-FUM was extracted by the Miniprep Kit. PCR was then carried out using the BigDye 
terminator reaction mix. DNA in PCR samples were precipitated by EtOH containing EDTA 
and wash by 70% EtOH. Samples were resuspended in HiDye formamide, boiled, and cooled 
on ice and then sequenced. Primers used for sequencing are M13 forward and reverse primers. 
The sequencing overlap can be seen in figure 12. M13 primers will start sequencing a few 
base upstream or downstream of start and stop codon. As during sequencing, the first few 
bases sequenced is without credibility, it seems important to choose primers that will start 
amplification far enough from the start and stop codon. 
 
Figure 13 Sequencing of colony 7. As it can be seen, no clear results were obtained 
 
As shown in figure 13, sequencing of the gene from colony 7 failed. On the other hand, 
successful sequencing of the gene from colony 1 was achieved using forward primer (data not 
shown) and sequence homology reached 100% compared to predicted sequence. The 
sequencing using reverse primer also showed 100% homology after analysis of sequence 
wave profile (figure 14). These results demonstrated successful modification of FUM genes 
for expression in S. cerevisiae. 
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Figure 14 Details of sequencing of colony 1. It can be seen that 4 G were found from nucleotide 793 to 796, while the 
graph shows only 3 peaks and therefore 3 G only. 
 
 
BLAST analysis/T-coffee 
 
Since the sequence of fumarate hydratase from T. thermophilus is available only in strain 
HB27, a blast analysis was performed on fumarase from T. thermophilus HB8, the strain used 
in this study. The blast analysis demonstrated that it shares a 100% similarity with fumarate 
Hydratase from T. thermophilus HB8. It so appears that fumarase of S. cerevisiae and the one 
of T. thermophilus share approximately 60% of affinity (results found by comparing the two 
sequences with T-coffee and ClustalW2).   The Blast analysis with the search set modified for 
S. cerevisiae (taxid:4932) results show a 98% coverage with fumarase [Saccharomyces 
cerevisiae] (accession number AAA66909.1), with a E-value equal to 3e-150. 
 
Part 2: Yeast transformation 
To construct expression plasmid of FUM gene in yeast, the correctly modified FUM gene 
was transferred from pBS-FUM to yeast expression plasmid p803 by digestion with EcoRI 
and SalI and following ligation using ligation mix. Resulting plasmid was designated as p803-
FUM. DH5α was transformed with p803-FUM plasmid and grown on LB-Amp medium. 
Colonies obtained were then checked by colony PCR.  
         L            1  
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Figure 15 pBS digested with EcoRI and SalI. Lanes; L: 2-log ladder 6 μL; 1: 30 µL of digestion of 20 µL of purified pBS with 
EcoRI and SalI and 3 µL of dye. 
 
As shown in figure 16, colony 6 has no plasmid, while colony 4 and 5 didn’t give any clear 
results. Colony 10 was then chosen for amplification of plasmid, and inoculated in a 5mL LB-
amp tube.  p803-FUM plasmid was then extracted using the miniprep protocol. 
 
 
 
Figure 16 colony PCR of DH5α bacteria cells transformed with p803-FUM plasmid for plasmid amplification. ; L: 2-log 
ladder 6 μL; C1-C11, colony PCR of colony 1 to 11 
 
Using p803-FUM, yeast cells (strain BY5208) were transformed by the ZYMO kit. 
Competent yeasts were created thanks to the kit first step. Cells were then transformed with 
the kit second step, based on the LiAC/SS carrier method. The newly transformed yeasts were 
then plated on a SD+HIS plate. Rosetta cells were also transformed by pet11a-FHA in order 
to produce FUM in both microorganisms. 
  L   C1   C2   C3  C4   C5       L C6  C7 C8 C9 C10C11 L 
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Figure 17 Yeast colony PCR. Lanes: L: 2-log DNA ladder. C1 to C5 : 5 different colonies. Amplification done by M13 
primers 
 
Colony PCR protocol was first optimized for yeasts and successful results were obtained. 
The results of colony PCR of BY5208 containing p803-FUM can be seen in figure 17. The 
bands corresponding to fum were confirmed in colonies 1 and 2. This result indicated that 
successful introduction of p803-FUM into BY5308 strain. The growth of BY5208-FUM was 
monitored (figure 18). By monitoring the OD at 600 nm, it can be found that around 20 hrs of 
incubation is enough to harvest cells being still in the exponential phase.  
 
 
Figure 18 Growth curve of BY5208-FUM in SD+HIS. Three different cultures were used. The trend line is an order 4 
polynomial curve 
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Part 3: Protein production and extraction 
 
To confirm whether introduced FUM gene was correctly expressed in E. coli and yeast 
strains or not, protein production was investigated by SDS-PAGE. Protein extract for SDS-
PAGE from Rosetta cells harboring pET11-a-FUM plasmid that contains FUM gene in 
pET11-a plasmid were obtained after induction of IPTG, resuspension in PBS, sonication and 
mix with SDS sample buffer. In the case of yeast, three different protocols were followed in 
order to obtain protein extract for SDS-PAGE. The first protocol followed is the same of the 
Rosetta protocol, without induction by IPTG. Samples were resuspended in PBS and 
sonicated. The second protocol is the so-called post-alkaline extraction (PAE). Cells were 
treated by 0.2M NaOH, incubated 5 min at room temperature, pelleted and resuspended in 
SDS sample buffer. The last protocol is the glass beads with DTT incubation (GB-DTT) 
protocol, from LeBel et al. Cells were harvested, washed with water, rinsed twice with 
TMG/NaCl buffer, resuspended in TMG/NaCL/DTT buffer. Glass beads were added and 
samples were vortexed 30 sec, and then kept on ice 30 sec. This was repeated 25 times. After 
the transfer in new microtubes, samples were centrifuged and mix with sample buffer for SDS.  
 
First trial was carried out using sonication and PAE method. As shown in figure 19, no band 
corresponding to FUM gene product (ca. 50 kDa) was observed for samples from yeast strain 
(lanes 1 to 6). On the other hand, thin bands were observed for samples from E. coli strains 
(lanes 7 to 10). Second trial was carried out using PAE and GB methods for yeast and 
sonication method for E. coli. Samples from E. coli shows clear band corresponding to size of 
FUM was observed in any conditions (lanes 7 to 12), while samples from yeast showed band 
only in the case of using PAE method (lanes 13, 17, and 18).  
 
 
          L        1    2    3     4    5    6      L               L    7     8    9   10 
Figure 19 SDS-PAGE first attempt. L = protein ladder 3µL; 1: yeasts transformed with p803-FUM, post-alkaline extraction; 2: 
yeasts transformed with p803-FUM, post-alkaline extraction from frozen cells; 3: yeasts transformed with p803-FUM, sonication; 4: 
yeast cells not transformed, post-alkaline extraction; 5: yeast cells not transformed, post-alkaline extraction, from frozen cells; 6: 
yeasts not transformed, sonication; 7-10: rosetta-pet11-a-FUM, sonication, from 4 different colonies 
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Figure 20 SDS-PAGE Second attempt. L : Ladder 3µL ; 1 : Yeast-FUM glass cell lysis; 2: Yeast-FUM glass cell lysis, 70°C 
20min; 3: yeasts not transformed, glass cell lysis; 4: yeasts not transformed, glass cell lysis, 70°C 20min; 5: Rosetta-FUM, 
colony 6; 6: Rosetta-FUM colony 6, 70°C 20min; 7: Rosetta-FUM, colony 5; 8: Rosetta-FUM colony 5, 70°C 20min; 9: 
Rosetta-FUM, colony 4; 10: Rosetta-FUM colony 4, 70°C 20min; 11: Rosetta-FUM, colony 3; 12: Rosetta-FUM colony 3, 
70°C 20min; 13: Yeast-FUM post-alkaline extraction, 10µL; 14: Yeast not transformed, post-alkaline extraction, 10µL; 15: 
Yeast SD+HIS medium,70°C, 20min 30 µL; 16: Yeast SD+HIS medium 30 µL; 17: Yeast-FUM post-alkaline extraction, 70°C, 
20min 6µL; 18: Yeast-FUM post-alkaline extraction, 6µL; 19: Yeast YPD medium from untransformed cells, 70°C, 20min, 
30 µL; 20: Yeast YPD medium from untransformed cells 30µL; 21: yeasts not transformed, post-alkaline extraction, 70°C, 
20min, 6µL; 22: yeasts not transformed, post-alkaline extraction, 6µL. Arrows show the band that is meant to be 
fumarase 
Trial for protein extraction from yeast cells was again carried out by GB method. This 
extraction was checked by spectrophotometry as well as SDS-PAGE. Due mainly to the 
presence of tyrosine and tryptophan, proteins exhibit a distinct UV light absorption maximum 
at 280 nm [Layne, 1957]. Nucleic acid, which absorbs strongly light at 260 nm, also slightly 
absorbs at 280 nm. Possible contamination by nucleic acids can unfortunately happen during 
glass beads extraction. Grove equation can be used, in order to reduce this contamination as 
follows. 𝑃𝑟𝑜𝑡𝑒𝑖𝑛 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 �𝑚𝑔
𝑚𝐿
� = 1.55 × 𝐴𝑏𝑠280 −  0.76 × 𝐴𝑏𝑠260 . 
 
 
Figure 21 Protein concentration after glass beads extraction. 2 min samples was shaken for 1 min then kept on ice 
1 min. This was repeated twice. 4 min sample was shaken for 1 min then kept one ice 1 min. This was repeated 4 times. 
Final OD value found were transformed by the Grove equation.  This result was done in triplicate 
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As shown in figure 21, protein production was confirmed in yeast strain using GB method as 
the extraction samples showed absorption at 280 nm. SDS-PAGE results also showed the 
bands corresponding to FUM gene product by both PAE and GB method (figure 20). These 
results showed successful expression of FUM in yeast and E. coli and that PAE and GB 
methods are suitable methods for extraction of proteins from yeast. 
 
 
Figure 22 SDS-PAGE of Yeasts samples by PAE and GB. Lanes: L: Ladder; 2: 30 µL of Y-PAE; 3: 2 µL of Y- GB 2minutes; 4: 5 
µL of Y-GB 2 min; 5: 10 µL of Y- GB; 6: 20µL of Y- GB; 7: 40 µL of Y- GB; 8: 0.5 µL of Y- PAE; 9: 4 µL of y- PAE; 10: 0.1 µL of Y 
PAE  
Part 4: In vitro Enzyme Analysis 
Enzyme assay 
 
Table 8 Units/mL of enzyme of FUM. Three different extraction techniques were used (result done in triplicate). 
 Units/mg of cells Standard deviation 
Rosetta-FUM 0.51 0.15 
Yeast-FUM Post Alkaline 
Extraction 
0.017 0.0001 
Yeast-FUM Glass Beads 0.033 0.01 
Encouraged to the result that both strain successfully produced FUM, enzyme activity was 
measured in vitro by spectrophotometer. By mixing protein extract containing FUM, buffer, 
substrate, co-factor and water, and heating this mixture at 70°C,  
Fumarate production or consumption were monitored at 240 nm. Enzyme activity was first 
checked at 240 nm. Unfortunately, it appeared that the spectrophotometer results are really 
unstable at such a low wavelength. To overcome this problem, FUM was used coupled with 
ME. FUM converts FA to LMA and ME can convert LMA to pyruvate in the presence of 
NADP+. Therefore FUM activity can be measured by monitoring NADPH production. As 
shown in Table 8, both strains successfully produced FUM with retaining its activity. 
It was first proven that the absorbance measured is really due to FUM activity and that ME 
concentration is high enough for not having any impact on the reaction rate. This was done by 
         2   L  3  4    5    6    7   L   8   9  10 
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measuring the absorbance with different concentrations of FUM. If the concentration of FUM 
is increased by two, absorbance should also increase by two. This was proven and those 
results were triplicated (data now shown) 
In vitro leakage assay 
To evaluate enzyme leakage from cells, SN as well as cell extract samples were prepared 
after different incubation time at 70°C. Protein concentration per mL of enzyme was then 
calculated by the Bradford assay. As shown in figure 23, half of proteins leaked in early phase 
of incubation using E. coli, while proteins derived from yeast strain gradually leaked. After 
3 hrs of incubation percentage of leakage of yeast reached that of E. coli. These results 
indicated that protein was more stably retained in yeast cells than E. coli cells. 
 
 
Figure 23 Percentage of leakage in bacteria and yeast cells, over time. In vitro (result done in triplicate). 
In vitro leakage assay in the presence of cations 
 
To the purpose of preventing enzyme leakage, whole cells of S. cerevisiae as well as E. coli 
were pre-incubated 4 hrs with different divalent cations. Manganese (Mn) and Calcium (Ca) 
were tested. Results of incubation with different concentration of MnCl2 and CaCl2 were 
shown in figures 24 and 25. The final percentage of leakage for every sample was compared 
with the leakage obtained for the control sample (same incubation time, without ion). As 
shown in these figures, addition of divalent cation brought in decrease of enzyme leakage in 
yeast while enzyme leakage increases in E. coli. Since high concentration of CaCl2 (> 10 
0
10
20
30
40
50
60
70
80
0 50 100 150 200 250
Pe
rc
en
ta
ge
 o
f L
ea
ka
ge
Minutes of incubation
Leakage Assay
Rosetta
Yeast
 35 
 
mM) brought in inactivation of FUM (Table 9), addition of 5 mM of is preferable for 
preventing enzyme leakage in yeast. 
 
 
Figure 24 Leakage percentage with presence of CaCl2. It can be seen really clearly that leakage increases in Rosetta cells 
with presence of CaCl2, while SN activity was reduced by 94% in yeast cells. Enzyme unit with no ion was set to be 100%. 
This result shows the percentage of decreases of unit. 
 
Figure 25 Leakage percentage in presence of MnCl2.25mM MnCl2 for Rosetta sample was not tested. Enzyme unit with 
no ion was set to be 100%. This result shows the percentage of decreases of unit. 
 
Table 9 Percentage of enzyme activity in presence of CaCl2. Enzyme unit with no ion was set as being 100%.  
CaCl2 
concentration 
25 mM 10 mM 5 mM 1 mM 
Rosetta inactivati
on 
Inactivati
on 
160% 142% 
Yeasts inactivati
on 
Inactivati
on 
231% 204% 
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Part 5: L-malic acid production 
L-malic acid detection 
Since FUM activity was confirmed in both yeast and E. coli strains, LMA production from 
FA was carried out. Before carrying out the production, some preparation was carried out. It 
first of all appeared important to check the detection limit of LMA by HPLC. Different 
concentrations of LMA in solution were used. As shown in Table 10, 0.15 mM seems to be 
the detection limit of LMY by HPLC. 
Table 10 L-malic acid detection limit by HPLC 
 
L-Malic acid detection limit 
 
 
0.15mM 
 
Fumaric acid solubilization 
Subsequently, solubility of FA was investigated. As the enzymes used in this study are TEs, 
they have an ideal working temperature around 70°C that is far from conventional condition. 
The substrate used in this study, FA cannot be dissolved in water at RT with a low 
concentration equal to 100 mM. Its solubility was tested at different temperatures, up to 73°C, 
as shown in figure 26. At 50°C, around 100 mM could be dissolved in water. At 60°C, the 
highest concentration was observed, being equal to nearly 240 mM. This experiment was 
triplicated, and only the highest concentration dissolved in shown in figure 26.  
 
 
Figure 26 Fumaric acid solubility. This result was triplicated and only the highest concentration found from the 
triplicate experiment is shown on this figure. 
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L-malic acid production 
After preliminary experiments mentioned above, LMA production was carried out. 
Principles of SME were applied during the whole cell experiments. Untreated cells were 
resuspended in phosphate buffer, and incubated at 70°C for 20 min. After having cooled them 
down on ice, FA was added, up to a concentration of 10 mM. Cells were then incubated at 
70°C for different period of time. Reaction was stopped by adding the same volume than the 
sample volume of phosphate buffer, and samples were cooled down on ice. LMA production 
was then evaluated by HPLC.  
LMA production was first checked up to 2 hours (figure 27). Yeasts cells were used with a 
concentration of 80 mg/mL. Rosetta cells were used with a concentration of 40 mg/mL. 
Long-termed LMA production was also carried out to check the bioconversion after 2 hours. 
As shown in figure 28, conversion using Rosetta reached approximately 90% really fast, 
while conversion using yeast cells reached approximately 80% even after 5 hours.  
 
Figure 27 LMA production from 0 to 120 minutes. The percentage of bioconversion is shown. Results were done in 
triplicate.  
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Figure 28 L-malic acid production for different periods of time over two hours 
Leakage assay 
Enzyme leakage from cells was also tested in whole cell experiment. Yeast cells over-
expressing FUM were incubated at 70°C for 1, 2 and 3 hours. After centrifugation, SN and 
cells were kept separately and cells were resupsended in phosphate buffer. FA was then added 
to both cells and SN sample to final concentration of 10 mM. All samples were then incubated 
3 hours at 70°C. Reaction was then stopped by adding phosphate buffer, and samples were 
cooled down on ice. After centrifugation, 100 µL of sample was subjected to HPLC analysis. 
As shown in Table11, no LMA was produced using SN samples. This result indicated that 
most of enzyme was kept in yeast cells after 2 and 3 hours incubation at 70°C. 
Table 11 Bioconversion of FA to LMA, after 2 and 3 hours of incubation at 70°C. SN was then collected, and incubated 
with FA (10 mM) for 3 hours. Result was done in triplicate 
Time of incubation [hour] 2 3 
Bioconversion 0 0 
 
Part 6: Reusability assay 
 
To confirm whether FUM-expressing cells can be used for several batch reactions, 
reusability assay was performed over four hours. Whole cells of Rosetta and yeast that over-
expressing FUM were incubated 20 min at 70°C. FA was then added up to a concentration of 
10 mM. Samples were then incubated up to two hours at 70°C. After two hours, samples were 
centrifuged and cells were kept and washed with 0.2% phosphate buffer. Phosphate buffer and 
water and 10 mM FA were then added. Samples were incubated at 70°C for up to two hours 
again. LMA production and FA consumption were measured by HPLC. As shown in 
figure 29, conversion rate of FA to LMA dramatically decreases when second batch reaction 
was carried out using E. coli cells. On the other hand, conversion rate of FA to LMA did not 
decrease when yeast cells were used (figure 30). The same experiment was also carried out, in 
presence of MnCl2 (figures 29 and 30). 10 mM of MnCl2 final concentration was used. MnCl2 
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was added directly when the cells were mixed with water. Cations were therefore present for 
the pre-incubation of 20 min. These results strongly indicated that yeast cells expressing FUM 
have reusability and can be used for repeated reaction. 
 
 
Figure 29 Reusability assay over 4 hrs for Rosetta over expressing FUM. Result was done in duplicate. 
 
 
Figure 30 Reusability assay for Yeast samples over expressing FUM over 4 hrs. Result was done in duplicate 
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Part 7: Yeast cells characteristics 
Pictures of cells 
By simply looking at the heated samples, it seemed that E. coli cells lyses more easily than 
S. cerevisiae cells.  In order to confirm this point of view, pictures of cells were taken under 
microscope, 40 x 0.60, Plan Fluor, Ph2 DM ELWD. Rosetta and yeasts cells before heat 
treatment can be seen in figure 31. As it can be seen in this, bacterial cells are too small to be 
correctly seen under this magnification. Nevertheless, yeast cells were heated 30 min at 70°C 
and a picture was taken after heat treatment. This can be seen in figure 31. No difference in 
either size or shape can be seen. It would nevertheless be interesting to take pictures of the 
cells with a higher magnification, in order to be able to see more clearly the membrane 
structure. 
 
 
Figure 31 Yeast and Rosetta sample A Yeast cells B Yeast cells after 30 min heat treatment C Rosetta cells D Yeasts and 
Rosetta cells after heat treatment 
Sedimentation assay 
In order to prove the advantage of yeasts cells compared to E. coli cells, sedimentation of 
cells was tested. This was carried out by monitoring the OD600 or OD660, for yeasts and 
bacteria respectively, over approximately 3 hours, in a cuvette where the bottom and the top 
was hidden. Only an area of approximately 1cm2 was still not hidden.  As shown in figure 32, 
yeast cells showed better sedimentation property than E. coli cells. 
 
A B 
D C 
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Figure 32 Sedimentation assay. In red: E. coli cells, measured at OD660. In blue: Yeast cells, measured at OD600, for 2 
hours and 20 min, approximately 
 
Table 12 Sedimentation Ratio after 8,000 seconds (2.22 hours) 
Sedimentation Ratio After 2.22hours  
E. coli ~100% 
Yeast 28.88% 
 
A better separation of biomass by yeast cells can also be seen by looking at micro tubes used 
for the application of SME. In figure 33, Rosetta and yeast cells at a concentration equal to 
100mg/mL were incubated at 70°C. After the heat treatment, bacteria cells seem to have lysed, 
as the sample become really sticky. After centrifugation of 5,000 rpm (5 min, 4°C), it is not 
possible to separate bacterial cells from SN (figure 31.B). In the case of yeasts, 5 min 
centrifugation is enough to separate cells from SN.  
 
Figure 33 A: Rosetta cells after incubation at 70°C; B: Rosetta cells after incubation at 70°C and centrifugation at 5,000 
rpm; C: Yeast cells after incubation at 70°C; D: Yeast cells after incubation and centrifugation at 5,000 rpm  
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VII. Discussion 
The first part of this project was the construction of the correct plasmid, in order to produce 
FUM in S. cerevisiae. This was carried out by ligating fum, the gene encoding fumarase, on 
p803 plasmid, given by the NBRP. The restriction sites on the plasmid were first checked and 
fum already available in our laboratory was modified. Those modifications were checked by 
sequencing, and fum was then ligated on p803 plasmid. Finally, the newly ligated plasmid was 
amplified in E. coli.   
Part 1 Plasmid creation 
Enzymes restriction 
Results in figure 5 showed that XbaI digests the plasmids at two different sites as two size of 
band was observed. Unfortunately, this was not mentioned on the plasmid map given (this can 
be seen in figure 1 as well as appendix). The restriction site seems to be unique. This result 
was duplicated and confirmed that XbaI digests both plasmids (p803 and p804) at two 
different sites, giving an approximately 3,000 bp-length and a 4,000 bp-length fragments. It 
can also be seen that XbaI does not remove the stuffer DNA. 
As the sequence of stuffer cDNA is unknown, there is the possibility that XbaI digested in 
the middle of stuffer DNA. However, this digestion does not give 4,000 bp and 3,000 bp-
length bands. Another possibility could have been a contamination during the digestion. This 
seems nevertheless unlikely, as all digestions have been at least duplicated. The reason is 
unclear, but there seems to be something wrong in given sequence of p803 and p804. 
Figure 5 also showed that XhoI removes the stuffer DNA only in plasmid p803, and not in 
plasmid p804. Unfortunately, XhoI also digests fum. Therefore, XhoI is not available for 
cloning of fum. 
Digestion of the plasmids with EcoRI and SalI was performed and the stuffer was correctly 
removed from p803, but not p804 (figure 7 and 8). In addition, EcoRI and SalI sites are not 
contained in fum. Therefore, p803 was chosen as the vector plasmid for plasmid construction. 
The digested plasmid was retrieved from the gel, thanks to the GE Kit in approximately 40 μL 
of MilliQ water.  
In all the results obtained, it can be seen that the plasmids are around 7,000 bp, which was 
corresponding to the size from given information. The stuffer removed in figures 7 and 8 
seems to be approximately 400 bp-length. Since the length of stuffer DNA is 300 bp, it is 
considered that enzyme sites exist near the stuffer DNA. It is still not sure if plasmid p804 
contains a stuffer DNA or not. With all the digestions done, no stuffer was removed. 
Gene modifications 
On figure 9, a consensus sequence composed of AAAATG seems to be the most appropriate 
one for S. cerevisiae. This figure was created with seqLogo [Schneider et al., 1990], by 
retrieving sequences from UCSC Table browser, with the genome of S. cerevisiae assembled 
in 2008 (track SGC gene strand + and entire genome). The perl code used to create the 
sequences database can be found in appendix. 
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Studies about the translation initiation regions of S. cerevisiae have already been done 
[Hamilton et al., 1987]. It was proven that the start codon context is different from animal 
mRNAs [Kozak, 1987], with a consensus sequence shown in figure 34. In S. cerevisiae, no 
exception from AUG start codon was found. In highly expressed genes, the consensus 
sequence of RBS would be AAAAAA ATG TCT, with a C avoided in the +4 position, G 
avoided in the leader position and an A in positions -1 to -6 at more than 50% [Hamilton et al. 
1987]. 
 
Figure 34 Consensus sequence for the AUG context in highly expressed genes [Hamilton et al., 1987]  
 
In lower eukaryotes, such as S. cerevisiae, AUG is the only codon recognized as the 
translational initiator [Chang and Wang, 2004, Hamilton et al., 1987]. Therefore, if the first 
AUG codon is mutated, initiation of translation begins at the next available AUG on the 
mRNA. Yeasts cannot efficiently use non-AUG codon as translation start sites. Examples of 
native non-AUG initiation have not been reported in S. cerevisiae.  
Table 13 Codon Usage Table (modified from http://crumb.stanford.edu/community/codon_usage.shtml), from 435 
genes found in GenBank 63 
 
Amino Acid Codon Number /1000 Fraction Percentage 
End TGA 151.00 0.70 0.34 34% 
End TAG 78.00 0.36 0.17 17% 
End TAA 219.00 1.10 0.49 49% 
Met ATG 4610.00 21.31 1.00 100% 
 
As shown in Table 13, ATG is the most frequent start codon and TAA is the most frequent 
stop codon in the yeast strain used in this project. For proper protein production in 
S. cerevisiae, it seemed therefore important to modify at least the start codon and add a poly-
A before the initiation codon as well as restriction enzymes sites on both ends. Six A were 
then added upstream of the start codon after the restriction enzyme site. EcoRI was added on 
the forward primer, while SalI was added on the reverse primer to be able to ligate the gene of 
interest into p803 plasmid. Primers sequence is shown in Table 3.  
The electrophoresis result after PCR of fum is shown in figure 10. The size of amplified gene 
was 1,400 bp that is corresponding to expected size, and this result indicates that the PCR 
have worked correctly. PCR conditions did not need to be optimized. This was one of the 
issues that could have been raised, as extremophiles are known to have a high GC content. It 
also seems that the concentration obtained is high. The modified gene was purified from the 
gel with the GE Kit and dissolved in approximately 40 μL of MilliQ water. 
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Sequencing of gene modifications 
Before transformation of S. cerevisiae, it is important to sequence the modified gene. 
Ligation of the gene with pBS allows an easier sequencing. pBS was digested in a blunt end 
manner, which reduces its efficiency. The ratio of the gene to be ligated and pBS is really 
important and colonies can be obtained only if this ratio is optimal. Thanks to the blue/white 
screening, colonies that have integrated gene will appear white.  As a control, bacteria were 
also transformed with circular pBS. All of them appeared blue, as expected. 
Only white colonies were picked and insertion of fum was confirmed by colony PCR as 
shown in figure 11. Blue colonies were also picked as controls. None of them had the insert 
(data not shown).  
As shown in figure 13, colony 7 did not give any results for sequencing. However, 
homology reached 100% for colony 1 for the forward sequencing. Only one nucleotide on the 
reverse sequencing seemed to be out of place. By looking at figure 14, which is a detail of the 
whole sequenced gene, it can be seen that the graph and the sequence found have small 
differences. From nucleotide 793 to 796, the sequence found was GGGG while the graph 
shows only 3 distinct black peaks. Therefore, the graph can be trusted more than the sequence 
given by the sequencer program. The modified gene reached 100% homology for the forward 
and reverse sequencing and every expected change were introduced into fum. These results 
showed successful modification of fum. 
The correctly modified gene from colony 1 was then digested from pBS plasmid by EcoRI 
and SalI. The digested gene can be found in figure 15. The two bands were obtained and one 
had approximately 1400 bp-length, which is corresponding to the length of fumarase gene, 
and the other had approximately 3,000 bp-long, which is corresponding to the length of pBS 
plasmid digested. The gene was retrieved from the gel using the GE kit. 
FUM was then ligated into p803 pre-digested and amplified in E. coli. After the retrieval of 
the plasmid from E. coli, S. cerevisiae cells were transformed.  
Part 2: Yeast transformation 
After transformation of yeast cells, and three days of incubation at 30°C, a dozen of colonies 
could be seen. 5 were picked to check the insertion of p803-FUM. As shown in figure 17, 
only colony 1 and colony 2 carry the plasmid. Colony 2 was selected and plated again on an 
SD + HIS plate. This colony is the only one used for all the future experiments. The plasmid 
used in this study carries a dual host capacity. It can therefore be amplified in bacteria and 
expressed in yeasts [Hadfield in Johnston et al., 1994]. It also carries the 2 μm ORI. This 
implies that, depending on the transformants, expression level can be different. 
This study shows the first trial of SME in yeast cells. SME was proven to be really 
successful in E. coli [Honda et al., 2010; Iwamoto et al., 2007; Restiawaty et al., 2011]. SME 
was also applied on Rhodococcus opacus [Klinger J., Master thesis, 2010]. In that trial, it 
appeared that a maximum of 60% bioconversion could be achieved. 
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Part 3: Protein production and extraction 
The production of FUM in yeast can then be checked by SDS-PAGE. It is also important to 
produce FUM in Rosetta, in order to compare both organisms. Rosetta were therefore 
transformed with pET11-a-FUM and grown in LB Cm Amp medium plates.  
The first attempt at SDS-PAGE is shown in figure 19. As it can be seen, a too low amount of 
protein extract was loaded for the Rosetta samples, while a too high amount of protein extract 
was loaded for the yeast samples. Yeast not transformed were also grown and used as a 
control and to compare the difference in protein production. As a result, from the first attempt, 
fumarase production could not be confirmed. It can nevertheless be found that sonication 
protocol does not work on yeasts. This was actually assumed as yeasts membrane is different 
from E. coli membrane. 
The second attempt at SDS-PAGE is shown in figure 20.  Protein extract from yeasts cells 
transformed and not transformed was prepared with post-alkaline extraction as well as glass 
beads - DTT lysis. Every sample was separated in two portions and one of them was heated at 
70°C for 20 min. The samples derived from four different colonies of Rosetta were also 
prepared by sonication, and half of the samples were also heated at 70°C for 20 min. Yeasts 
medium from the transformed and the not transformed cells was also loaded in order to see if 
the protein is secreted or not. As it can be seen, the Rosetta samples gave satisfactory results 
as 50 kDa size of the bands corresponding to FUM were observed. No evident change 
between the heated samples and not heated samples can be seen. For yeast samples, it can be 
seen that GB - DTT lysis seems to have failed. Only PAE gave protein extract concentrated 
enough to detect on SDS-PAGE, even if a too high concentration was loaded on the gel. As 
same as for Rosetta samples, no evident difference with the heated sample compared to the 
non-heated samples can be seen. It can also be seen that no protein were stained in the 
medium samples. Therefore, it seems that no protein was secreted into YPD or SD+HIS 
medium.  
GB extraction was tried as shown in figures 21 and 22. Two different numbers of repetitions 
of shaking were carried out. 2 min of GB extraction showed slightly higher protein 
concentration than 4 min of GB extraction. Therefore, the samples after 2 min GB extraction 
were analyzed by SDS-PAGE as shown in figure 22. As a result, expression of fum was 
confirmed in both yeast and E. coli strains. Due to the 2 μm ORI, some transformants can 
have a lower expression level. Protein extract was checked by SDS-PAGE (date not shown) 
from different transformants by GB and no difference between intensity of FUM band were 
seen. 
 
Part 4: In Vitro Enzyme Analysis 
Enzymes are proteins that catalyze chemical reactions [Lodish et al., 2008; Claessen et al., 
1983]. They increase the rate of a reaction, without affecting its extent and without 
permanently changing their conformation. Michaelis and Menten showed that the rate of an 
enzymatic reaction is proportional to the substrate concentration, only if this one is low. At 
high concentration, the rate reached a maximal velocity Vmax, Vmax being proportional to the 
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enzyme amount.  This saturation is due to the binding of the substrate to a limited number of 
enzyme sites. The rate of formation of a specific product at a specific substrate concentration 
[s] is given by the so-called Michaelis-Menten equation 
𝑉0 =  𝑉𝑚𝑎𝑥 [𝑠][𝑠] + 𝐾𝑚 
where Km is the substrate concentration that yields a half-maximal reaction rate and is called 
Michaelis constant. The smaller the Km value, the faster the reaction, and therefore the more 
effective the enzyme is. The rates of reactions vary among enzyme. This rate was found in 
this study by spectrophotometer.  
 
The units/mL of enzyme is found by the following equation: 
𝑈𝑛𝑖𝑡𝑠
𝑚𝐿
𝑒𝑛𝑧𝑦𝑚𝑒 =  ∆(𝐴340/ min 𝑡𝑒𝑠𝑡 − ∆𝐴340/ min 𝑏𝑙𝑎𝑛𝑘) ∙ 𝑉 ∙  𝑑𝑓6.022 ∙ 𝑉𝑒𝑛𝑧  
Where  
V = Volume of assay [mL] 
Venz = Volume of enzyme used [mL] 
Df = Dilution factor 
∆𝐴340 = Difference in absorbance at 340 
nm per minute¨ 
6.022 = extinction coefficient of NADP+ 
This result was then converted per unit/mg of protein by dividing it by the mg of protein of 
enzyme (found by the Bradford Assay). It can also be converted to unit/mg of solid, by 
dividing it by the mg of cells / mL of enzyme. 
One unit of enzyme will convert 1.0 mmol of product to substrate per min.  
 
Enzyme assay  
The result of enzyme assay is shown in Table 8. As it can be seen, enzyme activity of cells is 
approximately 50 times higher for Rosetta samples than yeast samples extracted with PAE 
and approximately 15 times higher than the one for yeasts extracted with GB. This result 
clearly showed that expression level of FUM by Rosetta is higher than yeast one. It is 
therefore assumed that the bioconversion of FA to LMA will be more slowly for yeasts cells 
than bacteria cells.  
As PAE involves incubation with NaOH, it was anticipated that the enzyme activity would 
change. As it can be seen in Table 8, GB seems to be a better extraction method than PAE. It 
was therefore decided to use only GB for further extraction of proteins. In Table 8, the units 
of the enzyme are shown as per mg of cells. It is therefore difficult to know if FUM produced 
in yeasts is really less active than the one produced in Rosetta, or if this difference is due to 
the extraction method. It is believed that GB can extract 90% of proteins. This result was 
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triplicate and the average is also shown in Table 8. While enzyme activity is different between 
both strains, these results showed that FUM was expressed as active form in both strains. 
 
In vitro leakage assay 
One of the biggest problems of SME is the leakage of the enzyme out of the cell [Restiawaty 
et al., 2011; Tsuchido et al., 1985]. Therefore, after incubation of cells at 70°C for different 
period of time, enzyme leakage was estimated by measuring enzyme activity of SN samples 
in vitro. The unit/mg of protein was calculated from SN as well as remaining cells after 
centrifugation (proteins were extracted from those cells). The percentage of leakage shows the 
result of the following calculus % 𝑙𝑒𝑎𝑘𝑎𝑔𝑒 =  𝑈𝑆𝑁
𝑈𝑆𝑁+ 𝑈𝐶 , where USN represents the unit/mg of protein of the SN and UC 
represents the unit/mg of protein of remaining cells.  
 
 
Figure 35 In vitro leakage assay methodology. Yeast cells were first transformed by p803-FUM, and then culture for at 
most 3 days. Enzyme assay was carried out for remaining cells, SN as well as protein extracted before heat treatment. 
Cells culture was done up to three days for untransformed yeasts, while transformed yeasts and Rosetta were cultured 
up to 12 hours.  
 
The results of leakage estimation over time are shown in figure 23 (average of triplicate 
results). This figure shows the percentage of enzyme activity outside the cell compared to the 
overall enzyme activity. It can be seen that even after only 5 min, nearly 60% of enzymes 
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have leaked from bacterial cells. On the other hand, only around 35% of enzymes have leaked 
from yeast cells, even after 100 min of incubation. These results strongly insist that yeast 
becomes a useful host for SME as it can stably retain enzymes even at high temperature. 
In vitro leakage assay in presence of cations 
To prevent enzyme leakage, addition of divalent cation to reaction mixture was examined. 
As shown in figures 24 and 25, both cations inhibit enzyme leakage for yeast cells. On the 
other hand, addition of cations has a different impact on E. coli samples. A too high 
concentration of ion increases the leakage, while a low concentration of ion seems to not 
change the leakage value. Coupled enzyme assay was then performed in presence of different 
concentration of CaCl2.As shown in Table 9, high concentration of CaCl2, such as 25 mM and 
10 mM inactivated FUM, while 5 mM and 1 mM activated FUM. FUM from yeast was even 
more activated than FUM from bacteria.  
Part 5: L-malic acid production 
L-malic acid production 
As FUM was expressed in active form in both strains, LMA production from FA was carried 
out. As shown in figure 27, Rosetta cell bioconversion followed an exponential curve and 
reached 80%. Yeast cells bioconversion followed a linear curve and reaches 70% after two 
hours. Higher production rate of LMA in Rosetta cells was expected due to their higher FUM 
activity. LMA production from FA by S. cerevisiae has already been done. Wang and co-
workers [Wang et al., 1996] proved that the conversion of FA to LMA was possible with 
Brevibacterium flavum immobilized cells. Unfortunately, they found that succinic-acid was 
formed as a side-product. In the current study, no high concentration of side-product was 
found.   
Neufeld and coworkers [Neufeld et al., 1991] used immobilized cells of S. cerevisiae for 
conversion of FA to LMA. They could show that in free cells experiment, FA was converted 
to LMA as a rate equal to 65 mM g-1 hr-1. 87% of FA was converted to LMA in 45 min. This 
conversion rate is higher than the one found in this study, but the main advantage of SME is 
its easy application. Compared to SME, the protocol used by Neufeld and coworkers is more 
difficult. 
LMA is currently produced by chemical synthesis via hydratation of FA. This leads to a 
racemic mixture of malic acid, from which LMA should be purified. Another way currently 
followed to produce LMA is by enzymatic process [Wang et al., 1998, Wang et al., 1998].  
Presecki and coworkers [Presecki and Vasic-Racki, 2005] used permeabilized S. cerevisiae 
for the production of LMA. A study of different strain was done and a proposed model for 
batch production of LMA was also performed by Presecki and coworkers. They could prove 
that the permeabilization process removes the barrier for free diffusion across cell membrane 
and empties the cell of most of the small molecular weight cofactor. Overall the yeast strains 
tested, permeabilized Saccharomyces bayanus showed the highest activity. 
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Leakage assay 
During production of LMA using yeast, samples were collected and LMA production was 
also carried out using SN samples to estimate whether FUM leaks from yeast cells or not. As 
shown in Table 11, no LMA could be detected by HPLC after 3 hours of incubation. This 
result indicates that FUM did not leak to SN in detectable level from yeast cells. In vitro 
enzyme experiment uses a really small amount of substrate and a small enzyme concentration. 
In vitro experiment is more sensitive than HPLC. The fact that no product was detected by 
HPLC is therefore compatible with the fact that activity was found in the SN. 
 
Part 6: reusability assay 
Reusability assay 
Encouraged to the result, yeast cells stably retained FUM intracellular, repeated batch 
reaction was carried out to compare reusability of cells between E. coli and yeast. As shown 
in figure 29, Rosetta lost 40% of activity after first batch reaction.  
On the other hand, as it can be seen in figure 30, yeast cells did not show decrease of 
enzyme activity after first batch reaction. This successful result showed that nearly no enzyme 
was removed during the washing of the yeast cells. The leakage of the enzyme is considered 
as being one of the biggest problems of SME in E. coli. Yeasts cells seem to overcome this 
problem.  
Reusability assay in the presence of MnCl2 
In figures 29 and 30, it seems that MnCl2 presence does not really have an impact on the 
leakage from bacterial cells. It also seems that, at first, MnCl2 will have a negative impact on 
the enzyme activity. This seems to be the case also for yeast cells. This impact is nevertheless 
really small.  
Leakage during second batch experiment was tested in E. coli [Restiawaty et al., 
unpublished]. To overcome the leakage problem, it was proven that linking the protein of 
interest to a membrane protein of E. coli is suitable. This is nevertheless a really tedious 
protocol and shows clearly one of the major problems of E. coli for the application of SME. 
Bressler and coworkers [Bressler et al., 2002] attempted to use a bioreactor based on 
supported liquid membranes for production of LMA from FA. This complicated design 
ensures mass flow and feasibility of continuous production of LMA from FA. A conversion 
rate of 84% (above the calculated equilibrium value) was demonstrated. Continuous 
production of LMA was demonstrated and it is believed that yeasts can become cheap and 
accessible biocatalyst [Sikorski et al., 1989; Presecki and Vasik-Racki, 2005; Wang et al., 
1996]  
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Part 7: Yeast cells characteristics 
Sedimentation assay 
As shown in figures 31, yeast cells are bigger than bacteria cells. It is considered that yeast 
cells weight more than bacteria and they will show good sedimentation. After 130 min, 
approximately 15% decrease of the OD of yeasts cells was observed, while bacteria samples 
OD did not vary.  Sedimentation ratio after 2.22 hours is shown in Table 12.  
The advantage of using yeast over E. coli for use of a bioreactor was analyzed by 
Domingues and co-workers [Domingues et al., 2000]. It was proven in their study that yeasts 
are more resistant to contamination at a high-cell density than bacteria. As heat treatment is 
part of SME process, contamination should also be reduced. Those two promising facts shows 
that yeasts could be considered as a really good host for SME application 
 
Different yeast characteristics were also monitored. The results in this study show clearly 
that a better biomass separation can then be achieved with yeasts compared to bacteria. Yeasts 
are very well-known organisms, used in industry for production of proteins or ethanol. It can 
be added that the production of recombinant proteins for therapeutic uses in S. cerevisiae is 
nowadays done. One example would be rh Insulins, by Novo Nordisk, produced by secretion. 
Vaccines for Hepatitis B virus or Human Papilloma Virus are also produced in S. cerevisiae 
(Recombivax-HB, by Merck and Co, Engerix-B by GlaxoSmithKline, Gardasil, by Merck and 
Co.), as well as semi-synthetical molecules, such as Vitamin C and Artemisin [Walsch, 2010]. 
Yeasts are mainly used for their capacity to secrete proteins. Secretion of protein of interest is 
not wanted for application of SME. Plasmid used should therefore be cautiously chosen.  
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VIII. Conclusion 
 
In this study, SME was applied to S. cerevisiae cells, in order to produce LMA from FA. Fum 
was first modified in order to produce FUM in yeast cells. The modifications were confirmed 
by sequencing the gene. The correctly modified gene was then ligated to a YEp plasmid, p803, 
carrying GAP promoter. p803-FUM was amplified in E. coli cells and S. cerevisiae cells were 
transformed with the extracted plasmids.   
Enzyme production was confirmed using different protein extraction protocols by SDS-PAGE. 
The most suitable protocol for this study was the GB protocol. E. coli cells were also 
transformed to express FUM. FUM activity and LMA production were then compared 
between both microorganisms.  
FUM activity was first confirmed in vitro by coupling it with ME. In this study, the gene of 
interest was obtained from T. thermophilus, a thermophilic bacterium. The main advantages 
of performing processes at higher temperature are the reduction of microbial contamination, 
reduction of viscosity, improvement of mass transfer rate and substrates solubility [Bruins et 
al., 2001]. The main drawbacks are the instability of cofactors, substrates and products. In this 
study, the solubility of the substrate, FA, is increased with higher temperature. 
It appeared that expression level of FUM in yeast cells is less than that in E. coli. Nevertheless, 
a high percentage of bioconversion from FA to LMA was achieved with yeasts.  
Enzyme leakage during incubation at high temperature was tested for both microorganisms. It 
had already been reported that, by heating cells at such high temperature, leakage can happen 
[Restiawaty et al., 2011]. This is especially inconvenient for SME application as cells could 
not be re-used for bioconversion. Leakage of enzyme was therefore investigated in both 
microorganisms. Enzyme leakage was first estimated by in vitro enzyme assay. While enzyme 
leakage was observed to some extent in yeast cells, the level of leakage was less than that in 
E. coli. Enzyme leakage during LMA production was also carried out in yeast cells. After 
different period of heat treatment, reaction mixture was collected and SN was obtained. Using 
SN, conversion of FA to LMA was examined for up to 3 hours. No fumaric acid was 
produced even after 3 hours of incubation.  
Enzyme activity was also estimated in presence of cations in vitro. Two cations used in this 
study, MnCl2 and CaCl2 showed an impact on enzyme activity in SN. It was proven that 
CaCl2 has a negative impact on the enzyme activity.  
The reusability of cells was then checked, in presence and in absence of cations. MnCl2 was 
shown to have an impact of leakage by reducing it. It appeared that reusability of yeast cells is 
indeed better than bacterial cells. These results strongly demonstrated superiority of yeast as a 
host for SME as expressing enzyme stably retains in the cell and whole cell biocatalyst can be 
repeatedly used, while expression level of enzyme is less than in E. coli. 
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Table 14 Comparison between the two microorganisms used in this study: E. coli and S. cerevisiae 
 
 Escherichia coli Saccharomyces cerevisiae 
 Disadvantages Advantages Disadvantages Advantages 
Generalities  Well known host  Well known host 
 Easy cultivation  Easy cultivation 
 Fast growth Slow growth  
 Easy 
manipulation 
 Easy manipulation 
  
Growth on 
varieties of 
medium 
  
Growth on varieties of 
medium 
Small size of 
cells 
  Big size of cells 
Expression 
techniques 
 Easy 
transformation 
 Easy transformation 
 Used for 
production of 
many chemicals, 
pharmaceuticals, 
proteins, vitamins 
Mainly used 
for production of 
ethanol and 
protein 
 
  No secretion Secretion of 
protein 
 
Type Prokaryote Eukaryote 
Membrane Thin cell wall   Tough cell wall 
Tolerance Low pH tolerance   High pH tolerance 
from 3 to 9 
Protein 
production 
Cannot make 
post-translational 
modification 
  Post-translational 
modification partially 
possible 
Biomass Thin cell 
membrane 
  Thicker cell 
membrane 
Bad 
sedimentation 
  Good sedimentation 
No separation at 
low speed 
centrifugation 
  Good separation at 
low speed 
centrifugation 
Application 
of SME 
 Already proven 
to be successful  
First trial   
 Fast 
bioconversion 
Slow 
bioconversion 
 
 High expression 
level 
Low expression 
level 
 
Cell lysis at high 
temperature 
  Nearly no cell lysis at 
high temperature 
Enzyme leakage   Enzyme leakage 
partially reduced 
Safety Production of 
endotoxins 
  Considered as GRAS 
by the FDA 
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Characteristics of cells were also analyzed. Yeast cells are known to be bigger than bacterial 
cells. This is an advantage for a better separation of cells. It was proven that a better 
sedimentation is achieved with yeasts in this study. This means that a lower centrifugation 
speed is needed to separate yeast cells compared to E. coli cells. Moreover, their size being 
bigger, membranes or filter to remove cells could have larger pores. Despite such differences 
bring only a small advantage in academic research, sedimentation properties and size of cells 
are linked to cost of instruments and processes on industrial production.  
S. cerevisiae and E. coli are both well-known organisms and have already used for industrial 
production of pharmaceuticals, chemicals and proteins. Yeast cells are eukaryotes and have a 
thicker cell membrane. They are capable of post-translational modification, and glycosilation. 
They are also considered as GRAS by the FDA, while E. coli cells produce endotoxins. The 
membrane composition of both microorganisms is also different.  
In summary, the first trial of SME in S. cerevisiae was performed. Advantages and 
disadvantages of S. cerevisiae and E. coli are summarized in Table 14. It was shown that a 
good percentage of bioconversion could be achieved by yeast cells and enzyme stably 
retained in the cell, despite the fact that the enzyme expression level in yeast is lower. On the 
other hand, E. coli has advantage as the reaction rate is higher, while E.coli has the major 
drawback of enzyme leakage. Other features of both strains were also discussed in this thesis.  
The choice of microorganisms used for SME application ultimately depends on target 
product. Fulfillment of host strain for SME would bring expanded use of SME. This is the 
first report of using yeast as a host strain for SME. 
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X. Appendix 
1. Fumarate hydratase from T. thermophilus HB8 Nucleotides Sequence 
gtggaataccggattgagcgggacaccatgggcgaggtgcgggtgccggcggacaagtactggggcgcgcagac
ccagcgctccctggagaacttcaggatcgggaccgaccgcttccgcatgcccctggagatcatccgggcctacgg
gatgctgaagaaggcggccgcgagagccaacctggagctcggggagctccccgaggagatcgccaaggccatcat
ccaggcggccgaggaggtggtccaggggaagtgggacgaccacttccccctggtggtcttccagacgggcagcgg
cacccagaccaacatgaacgtcaacgaggtcatcgccaaccgggcctcggagatcctggggaagcctctggggag
caagtacgtccaccccaacgaccacgtgaaccgggggcagagctccaacgacaccttccccaccgccatgtacgt
ggccgtggccctggcgctccaccagaggctctatcccgcggtggaaggcctgatccggaccttcacggccaaggc
ccaggcctttgaccagatcgtcaaggtggggcggacccacctgatggacgccgtgcccatcaccctgggacagga
gatcggcagctgggccgcccagctcaagaccaccctcgccgccgtcaaggaaatggaaaagggcctctacaacct
cgccatcggcgggacggcggtgggcacgggcctcaacgcccacccccgctttggggagctcgtggccaagtacct
cgcggaggagacggggctccccttccgggtggcggagaaccgcttcgccgccctggccgcccacgacgagctggt
caacgtcatgggggccatccgcaccctggccggggccctgatgaagatcggcaacgacgtccgctggctcgcctc
cggcccctacgcgggcattggggagatcaccatccccgccaacgagcccgggtcctccatcatgccggggaaggt
caaccccacccaggtggaggccctcaccatggtggtggtccgggtctacggcaacgaccacaccgtggccttcgc
gggaagccaggggaacttccagctcaacgtctacaagccggtgatggcctacagcaccctggagagcatcaacct
cctcgcggacgccgtggcctcctttgacgcccatctggcccaggggattgagcccaacctggagcgcattgagga
gcacctgcagaagaaccccatgctggccaccgccctcaacaaggccatcggctacgacaaggcggcggagatcgt
taagaaggccctcaaggagaagaagaccctgaagcaggcggccctcgagctcggctacctcacggaggaggagtt
tgaccgcatcgtggtccccatgaggctcgccaagccccacgagggggcgtag 
2. Fumarate hydratase from T. thermophilus HB8, amino acid sequence 
MEYRIERDTMGEVRVPADKYWGAQTQRSLENFRIGTDRFRMPLEIIRAYGMLKKAAARANLE
LGELPEEIAKAIIQAAEEVVQGKWDDHFPLVVFQTGSGTQTNMNVNEVIANRASEILGKPLG
SKYVHPNDHVNRGQSSNDTFPTAMYVAVALALHQRLYPAVEGLIRTFTAKAQAFDQIVKVGR
THLMDAVPITLGQEIGSWAAQLKTTLAAVKEMEKGLYNLAIGGTAVGTGLNAHPRFGELVAK
YLAEETGLPFRVAENRFAALAAHDELVNVMGAIRTLAGALMKIGNDVRWLASGPYAGIGEIT
IPANEPGSSIMPGKVNPTQVEALTMVVVRVYGNDHTVAFAGSQGNFQLNVYKPVMAYSTLES
INLLADAVASFDAHLAQGIEPNLERIEEHLQKNPMLATALNKAIGYDKAAEIVKKALKEKKT
LKQAALELGYLTEEEFDRIVVPMRLAKPHEGA 
 
3. Fumarate hydratase information from Harima Riken Institute 
Thermus thermophilus HB8 TTHA0558 
Fumarate hydratase class II 
Category: Energy metabolism 
Locus: 1:complement(519024…520424) 
Synonym: TT0543 
Stop codon: TAG 
DNA Length: 466 
Molecular weight: 50889.05 
Absorption coefficient: 43680 
Number of methionine 15 
Expression Plasmid ID: PC010558-41 
Vector: pET11a 
PDB code: 1vdk 
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4. Enzymes that don’t digest fumarase gene [modified from nebcutter]
Acc65I (G^GTAC_C) 
AclI (AA^CG_TT) 
AflII (C^TTAA_G) 
AflIII (A^CRYG_T) 
AgeI (A^CCGG_T) 
AhdI (GACNN_N^NNGTC) 
AlwNI (CAG_NNN^CTG) 
ApaLI (G^TGCA_C) 
ApoI (R^AATT_Y) 
AscI (GG^CGCG_CC) 
AseI (AT^TA_AT) 
AsiSI (GCG_AT^CGC) 
AvrII (C^CTAG_G) 
BaeI 
(_NNNNN^NNNNNNNNNNAC 
NNNNGTAYCNNNNNNN_NNNNN^
) 
BamHI (G^GATC_C) 
BbvCI (CC^TCA_GC) 
BcgI 
(_NN^NNNNNNNNNNCGANNNNN
NTGCNNNNNNNNNN_NN^) 
BciVI (GTATCCNNNNN_N^) 
BclI (T^GATC_A) 
BfaI (C^TA_G) 
BglII (A^GATC_T) 
BlpI (GC^TNA_GC) 
BmgBI (CAC|GTC) 
BmtI (G_CTAG^C) 
Bpu10I (CC^TNA_GC) 
BsaI (GGTCTCN^NNNN_) 
BsgI (GTGCAGNNNNNNNNNN 
NNNN_NN^) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BsiWI (C^GTAC_G) 
BsmI (GAATG_CN^) 
BspCNI (CTCAGNNNNNNN_NN^) 
BspDI (AT^CG_AT) 
BspHI (T^CATG_A) 
BspQI (GCTCTTCN^NNN_) 
BsrDI (GCAATG_NN^) 
BsrGI (T^GTAC_A) 
BstAPI (GCAN_NNN^NTGC) 
BstBI (TT^CG_AA) 
BstEII (G^GTNAC_C) 
BstZ17I (GTA|TAC) 
Bsu36I (CC^TNA_GG) 
BtsI (GCAGTG_NN^) 
ClaI (AT^CG_AT) 
CspCI (_NN^NNNNNNNN  
NNNCAANNNNNGTGGNNNNNN
NNNN_NN^) 
DdeI (C^TNA_G) 
DraI (TTT|AAA) 
EcoRV (GAT|ATC) 
FseI (GG_CCGG^CC) 
FspI (TGC|GCA) 
HindIII (A^AGCT_T) 
HinfI (G^ANT_C) 
HpaI (GTT|AAC) 
EarI (CTCTTCN^NNN_) 
EcoP15I (CAGCAGNNNNNNNNN 
NNNNNNNNNNNNNNNN^NN_) 
EcoRI (G^AATT_C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KasI (G^GCGC_C) 
KpnI (G_GTAC^C) 
MfeI (C^AATT_G) 
MluI (A^CGCG_T) 
MlyI (GAGTCNNNNN|) 
NarI (GG^CG_CC) 
NdeI (CA^TA_TG) 
NheI (G^CTAG_C) 
NruI (TCG|CGA) 
NsiI (A_TGCA^T) 
PacI (TTA_AT^TAA) 
PciI (A^CATG_T) 
PflFI (GACN^N_NGTC) 
PleI (GAGTCNNNN^N_) 
PmeI (GTTT|AAAC) 
PshAI (GACNN|NNGTC) 
PsiI (TTA|TAA) 
PvuI (CG_AT^CG) 
RsrII (CG^GWC_CG) 
SalI (G^TCGA_C) 
SapI (GCTCTTCN^NNN_) 
SbfI (CC_TGCA^GG) 
SexAI (A^CCWGG_T) 
SfiI (GGCCN_NNN^NGGCC) 
SfoI (GGC|GCC) 
SgrAI (CR^CCGG_YG) 
SnaBI (TAC|GTA) 
SpeI (A^CTAG_T) 
SspI (AAT|ATT) 
SwaI (ATTT|AAAT) 
TfiI (G^AWT_C) 
Tsp45I (^GTSAC_) 
Tsp509I (^AATT_) 
TspRI (_NNCASTGNN^) 
Tth111I (GACN^N_NGTC) 
XbaI (T^CTAG_A) 
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5. Plasmid map of pNV11 [from http://yeast.lab.nig.ac.jp/cgi-
bin/nig/print_file.cgi?file=byp/BYP803.pdf ] 
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6. T-coffee alignment result (T_COFFEE, Version 8.93 (Thu Aug 5 2010) 
SCORE=99   BAD AVG GOOD 
cerevisiae   :  99 thermus      :  99 cons         :  99 
S.cerevisiae   mlrftncscktfvkssyklnirrmnssfrtetdafgeih 
T.thermophilus -------------------------meyrierdtmgevr 
cons                                     .:* * *::**:: 
   
S.cerevisiae   vpadkywgaqtqrsfqnfkiggarermplplvhafgvlk 
T.thermophilus vpadkywgaqtqrslenfrigtdrfrmpleiiraygmlk 
cons           **************::**:**  * **** :::*:*:** 
   
S.cerevisiae   ksaaivneslggldpkiskaiqqaadevasgklddhfpl 
T.thermophilus kaaaranlelgelpeeiakaiiqaaeevvqgkwddhfpl 
cons           *:** .* .** *  :*:*** ***:**..** ****** 
 
S.cerevisiae   vvfqtgsgtqsnmnanevisnraieilggkigskqvhpn 
T.thermophilus vvfqtgsgtqtnmnvnevianraseilgkplgskyvhpn 
cons           **********:***.****:*** ****  :*** **** 
 
S.cerevisiae   nhcnqsqssndtfptvvhiaaslqiqnelipeltnlkna 
T.thermophilus dhvnrgqssndtfptamyvavalalhqrlypaveglirt 
cons           :* *:.*********.:::*.:* :::.* * : .* .: 
 
S.cerevisiae   leakskefdhivkigrthlqdatpltlgqefsgyvq 
T.thermophilus ftakaqafdqivkvgrthlmdavpitlgqeigswaa 
cons           : **:::   ***:***** **.*:*****:..:.  
 
S.cerevisiae   qvengiqrvahslktlsflaqggtavgtglntkpgfdvk 
T.thermophilus qlkttlaavkemekglynlaiggtavgtglnahprfgel 
cons           *::. :  * .  * *  ** **********::* *.   
 
S.cerevisiae   iaeqisketglkfqtapnrfealaahdaivecsgalntl 
T.thermophilus vakylaeetglpfrvaenrfaalaahdelvnvmgairtl 
cons           :*: :::**** *:.* *** ****** :*:  **:.** 
 
S.cerevisiae   acslfkiaqdirylgsgprcgyhelmlpenepgssi 
T.thermophilus agalmkigndvrwlasgpyagigeitipanepgssi 
cons           * :*:**.:*:*:*.*   .*  *: :* ******* 
 
S.cerevisiae   mpgkvnptqnealtqvcvqvmgnnaaitfagsqgqfeln 
T.thermophilus mpgkvnptqvealtmvvvrvygndhtvafagsqgnfqln 
cons           ********* **** * *:* **: :::******:*:** 
 
S.cerevisiae   vfkpvmivnllnsirlitdaaysfrvhcvegikane 
T.thermophilus vykpvmaystlesinlladavasfdahlaqgiepnl 
cons           *  ***  . *:**.*::**. ** .* .:**:.*  
 
S.cerevisiae   prihelltkslmlvtalnpkigydaaskvaknahkkgit 
T.thermophilus erieehlqknpmlatalnkaigydkaaeivkkalkekkt 
cons            **.* * *. **.****  **** *:::.*:* *:  * 
 
S.cerevisiae   lkesalelgvltekefdewvvpehmlgp---k 
T.thermophilus lkqaalelgylteeefdrivvpmrlakphega 
cons           **::***** ***:***. *** ::  *     
 V 
 
7. 2-log DNA ladder 
 
 
2-log DNA Ladder visualized by EtBr  staining on a 1% TBE agarose gel. Mass values are for 
1µg/lane. Modified from http://www.neb.com/nebecomm/products/productn3200.asp 
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8. Thermus thermophilus genome [from Harima Riken Institute] 
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9. Thermus thermophilus, chromose 1, zoom on the fumarate hydratase 
gene 
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10. pET-11a information, from http://www.synthesisgene.com/vector/pET-
11a.pdf 
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11. Creation of S. cerevisiae RBS consensus sequence logo 
Steps followed to create RBS sequence list 
 
1. On UCSC table browser, Select clade, genome , assembly, group: "Genes and Gene 
Prediction Track"; track: "CCDC". Filter 
2. Output format: "selected fields from primary and related tables", click on "get output“; 
Select the fields 
3. Copy & paste the list of CDS position (without the header lines).  
4. Reformat the table browser output into .bed 
5. On the table browser main page, add custom track. Submit file.  
6. Get output as sequence. Add 10 extra bases upstream and 10 extra downstream, download 
sequence. 
7. Generate the sequence logo as follows: seqlogo -c -Y -f hs_cds_start.seq -F GIF -o 
hs_cds_start -k 1 M  
 
Perl Script 
#!/usr/bin/perl  
while(<STDIN>) {  
chomp; #reads one line after the other  
my @col = split /\t/, $_; #creation of first array  
my @exon = split /,/, $col[3]; #creation of second array, containing only the specific position  
my $end = $#exon; #$end contains the number of exon in the second array  
my $start = 1; # we don’t want the first exon  
for my $i ($start..$end) {  
print "$col[1]\t$exon[$i]\t$exon[$i]\t$col[0]\t0\t$col[2]\n";  
}  
}  
